| For: |
McFarland LV. Systematic review and meta-analysis of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i18/2202.htm |
| Number | Citing Articles |
| 1 |
Shu Guowei, Xin Yang, Chen Li, Dan Huang, Zhangteng Lei, Chen He.
Comprehensive optimization of composite cryoprotectant for
Saccharomyces boulardii
during freeze-drying and evaluation of its storage stability
. Preparative Biochemistry & Biotechnology 2019; 49(9) doi: 10.1080/10826068.2019.1630649
|
| 2 |
Sangita Paul, Asish Kumar Mukhopadhyay. Progress of bacteriophage as therapeutic agent against Helicobacter pylori, especially in India. Discover Applied Sciences 2025; 7(5) doi: 10.1007/s42452-025-06971-w
|
| 3 |
Yu Gu, Chen Wang, Xiali Qin, Bingqian Zhou, Xiang Liu, Tianyu Liu, Runxiang Xie, Jinghua Liu, Bangmao Wang, Hailong Cao. Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota. Pharmacological Research 2022; 181 doi: 10.1016/j.phrs.2022.106291
|
| 4 |
Alexandru Cosmin Pantazi, Adriana Luminita Balasa, Cristina Maria Mihai, Tatiana Chisnoiu, Vasile Valeriu Lupu, Mustafa Ali Kassim Kassim, Larisia Mihai, Corina Elena Frecus, Sergiu Ioachim Chirila, Ancuta Lupu, Antonio Andrusca, Constantin Ionescu, Viviana Cuzic, Simona Claudia Cambrea. Development of Gut Microbiota in the First 1000 Days after Birth and Potential Interventions. Nutrients 2023; 15(16) doi: 10.3390/nu15163647
|
| 5 |
Xin Yang, Guowei Shu, Zhangteng Lei, Guanli Du, Zemin Liu, Jili Cao. Effect of Carbon Sources, Nitrogen Sources and Prebiotics on Growth of Saccharomyces Boulardii
. Acta Universitatis Cibiniensis. Series E: Food Technology 2019; 23(2) doi: 10.2478/aucft-2019-0013
|
| 6 |
Abolfazl Mahyar, Parviz Ayazi, Haleh Pashaei, Banafsheh Arad, Sonia Oveisi, Shiva Esmaeili. The Effect of the Yeast Probiotic Saccharomyces boulardii on Acute Diarrhea in Children. Journal of Comprehensive Pediatrics 2021; 12(4) doi: 10.5812/compreped.117391
|
| 7 |
D. Dutta, F. Jafri, D. Stuhr, B. M. Knoll, S. H. Lim. A contemporary review of Clostridioides difficile infections in patients with haematologic diseases. Journal of Internal Medicine 2021; 289(3) doi: 10.1111/joim.13173
|
| 8 |
Roshanak Sambrani, Jalal Abdolalizadeh, Leila Kohan, Behboud Jafari. Recent advances in the application of probiotic yeasts, particularly Saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancer. Molecular Biology Reports 2021; 48(1) doi: 10.1007/s11033-020-06110-1
|
| 9 |
Anas Zaher, Jude Elsaygh, Stephen J. Peterson, Ilan S. Weisberg, Manish A. Parikh, William H. Frishman. The Interplay of Microbiome Dysbiosis and Cardiovascular Disease. Cardiology in Review 2026; 34(4) doi: 10.1097/CRD.0000000000000701
|
| 10 |
Mahsa Nayebhashemi, Somayeh Enayati, Mozhgan Zahmatkesh, Hamid Madanchi, Samaneh Saberi, Ehsan Mostafavi, Esmat Mirbzadeh Ardakani, Mohammad Azizi, Vahid Khalaj. Surface display of pancreatic lipase inhibitor peptides by engineered Saccharomyces boulardii: Potential as an anti-obesity probiotic. Journal of Functional Foods 2023; 102 doi: 10.1016/j.jff.2023.105458
|
| 11 |
Timothy D. H. Woo, Kentaro Oka, Motomichi Takahashi, Fuhito Hojo, Takako Osaki, Tomoko Hanawa, Satoshi Kurata, Hideo Yonezawa, Shigeru Kamiya. Inhibition of the cytotoxic effect of Clostridium difficile
in vitro by Clostridium butyricum MIYAIRI 588 strain.
Journal of Medical Microbiology
2011; 60(11) doi: 10.1099/jmm.0.033423-0
|
| 12 |
Jonathan Takahashi, J. Adam Rindfleisch. Integrative Medicine. 2018; doi: 10.1016/B978-0-323-35868-2.00105-5
|
| 13 |
Pietro Pozzoni, Alessia Riva, Alessandro Giacco Bellatorre, Maria Amigoni, Elena Redaelli, Anna Ronchetti, Mariangela Stefani, Rosangela Tironi, Edoardo Ennio Molteni, Dario Conte, Giovanni Casazza, Agostino Colli. Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Adult Hospitalized Patients: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Gastroenterology 2012; 107(6) doi: 10.1038/ajg.2012.56
|
| 14 |
Luis Vitetta, Emma Saltzman, Tessa Nikov, Isabelle Ibrahim, Sean Hall. Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. Journal of Clinical Medicine 2016; 5(11) doi: 10.3390/jcm5110102
|
| 15 |
T. M. Batista, E. T. A. Marques, G. R. Franco, B. Douradinha.
Draft Genome Sequence of the Probiotic Yeast Saccharomyces cerevisiae var.
boulardii
Strain ATCC MYA-796
. Genome Announcements 2014; 2(6) doi: 10.1128/genomeA.01345-14
|
| 16 |
Judit Villar-García, Juan J. Hernández, Robert Güerri-Fernández, Alicia González, Elisabet Lerma, Ana Guelar, David Saenz, Lluisa Sorlí, Milagro Montero, Juan P. Horcajada, Hernando Knobel Freud. Effect of Probiotics (Saccharomyces boulardii) on Microbial Translocation and Inflammation in HIV-Treated Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 68(3) doi: 10.1097/QAI.0000000000000468
|
| 17 |
P. Girard, M. Verleye, V. Castagné. Serotoninergic Mechanisms of Action in the Relaxant Properties of Saccharomyces boulardii CNCM I-745 on the Intestine. Digestive Diseases and Sciences 2025; 70(1) doi: 10.1007/s10620-024-08786-y
|
| 18 |
Lara Kern, Adin Tofield, John Frame, Eran Elinav. Next-generation probiotics: an outlook into current applications and future developments. Nature Reviews Microbiology 2026; doi: 10.1038/s41579-026-01311-0
|
| 19 |
Karoliny Brito Sampaio, Vincenzina Fusco, José Luiz de Brito Alves, Evandro Leite de Souza. Probiotics for Human Nutrition in Health and Disease. 2022; doi: 10.1016/B978-0-323-89908-6.00019-4
|
| 20 |
Stéphanie Blanquet-Diot, Sylvain Denis, Sandrine Chalancon, Fehd Chaira, Jean-Michel Cardot, Monique Alric. Use of Artificial Digestive Systems to Investigate the Biopharmaceutical Factors Influencing the Survival of Probiotic Yeast During Gastrointestinal Transit in Humans. Pharmaceutical Research 2012; 29(6) doi: 10.1007/s11095-011-0620-5
|
| 21 |
Nurcan Değirmencioğlu, Ozan Gurbuz, Yasemin Şahan. The Monitoring, Via an In vitro
Digestion System, of the Bioactive Content of Vegetable Juice Fermented with Saccharomyces cerevisiae
and Saccharomyces boulardii
. Journal of Food Processing and Preservation 2016; 40(4) doi: 10.1111/jfpp.12704
|
| 22 |
L. B. Lazebnik, A. S. Sarsenbaeva, E. B. Avalueva, L. S. Oreshko, S. I. Sitkin, E. V. Golovanova, S. V. Turkina, O. V. Khlynova, O. I. Sagalova, O. V. Mironchev. Clinical guidelines “Chronic diarrhea in adults”. Experimental and Clinical Gastroenterology 2021; (4) doi: 10.31146/1682-8658-ecg-188-4-7-67
|
| 23 |
Alexandra Imre, Renátó Kovács, Kitti Pázmándi, Dániel Nemes, Ágnes Jakab, Tünde Fekete, Hanna Viktória Rácz, Ilona Dóczi, Ildikó Bácskay, Attila Gácser, Károly Kovács, László Majoros, Zoltán Farkas, István Pócsi, Walter P. Pfliegler. Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces ‘boulardii’). Journal of Fungi 2021; 7(9) doi: 10.3390/jof7090746
|
| 24 |
Kerry L Ivey, Jonathan M Hodgson, Satvinder S Dhaliwal, Richard J Woodman, Richard L Prince, Kerry L Ivey. Cochrane Database of Systematic Reviews. 2013; doi: 10.1002/14651858.CD010445
|
| 25 |
Sarah H. Yi, John A. Jernigan, L. Clifford McDonald. Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals. American Journal of Infection Control 2016; 44(5) doi: 10.1016/j.ajic.2015.12.001
|
| 26 |
Luz Alba Caballero–Pérez, Rene Tejedor–Arias, Elaysa Josefina Salas–Osorio. Survival of a mixed culture of microencapsulated probiotic strains against the gastrointestinal barrier in vitro. Revista Científica de la Facultad de Ciencias Veterinarias 2023; (2) doi: 10.52973/rcfcv-e33296
|
| 27 |
Francisco Vargas-Albores, Estefanía Garibay-Valdez, Diana Medina-Félix, Marcel Martínez-Porchas. The micro-eukaryotic community: An underrated component of the mammalian gut microbiota?. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1123513
|
| 28 |
Janine Passos Lima, André Gonçalves Dias, Flávia dos Santos Gomes, Edmar das Mercês Penha. Indigenous Fermented Foods for the Tropics. 2023; doi: 10.1016/B978-0-323-98341-9.00020-7
|
| 29 |
Lynne McFarland. Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review. Antibiotics 2015; 4(2) doi: 10.3390/antibiotics4020160
|
| 30 |
Diego Cabral Lacerda, Paulo César Trindade da Costa, Luciana Caroline Paulino do Nascimento, José Luiz de Brito Alves. Probiotics for Human Nutrition in Health and Disease. 2022; doi: 10.1016/B978-0-323-89908-6.00022-4
|
| 31 |
Bruno K. Rodiño-Janeiro, María Vicario, Carmen Alonso-Cotoner, Roberto Pascua-García, Javier Santos. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Advances in Therapy 2018; 35(3) doi: 10.1007/s12325-018-0673-5
|
| 32 |
Xiaxin Zhu, Chi Zhang, Shuyan Feng, Ruonan He, Shuo Zhang. Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01304-4
|
| 33 |
Daniel Reyes-Rosario, Georgina G. López-Hernández, Juan Pablo Pardo, Guadalupe Guerra-Sánchez, Darío Rafael Olicón-Hernández, Daniel Uribe-Ramírez, Lucero Romero-Aguilar. Las levaduras como modelo clásico de alcances biotecnológicos. TIP Revista Especializada en Ciencias Químico-Biológicas 2025; 28 doi: 10.22201/fesz.23958723e.2025.752
|
| 34 |
Naflesia B.O. Corrêa, Francisco J. Penna, Fátima M.L.S. Lima, Jacques R. Nicoli, Luciano A.P. Filho. Treatment of Acute Diarrhea With Saccharomyces boulardii in Infants. Journal of Pediatric Gastroenterology and Nutrition 2011; 53(5) doi: 10.1097/MPG.0b013e31822b7ab0
|
| 35 |
Scientific Opinion on the substantiation of health claims related to Saccharomyces cerevisiae var. boulardii CNCM I‐1079 and defence against pathogenic gastro‐intestinal microorganisms (ID 913, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2012; 10(6) doi: 10.2903/j.efsa.2012.2717
|
| 36 |
R. Nithyatharani, R. Manikandan, M. Vinoth, R. Malathi. Functional Foods and Gut Microbiome. 2025; doi: 10.1515/9783112205150-009
|
| 37 |
Büşra Çınar, Deniz Koçan, Fatma Şahmurat. Saccharomyces boulardii CNCM I-745 as a Probiotic Adjunct in Kefir: A Proof-of-Concept Study Comparing Traditional Grain and Industrial Starter Cultures. Fermentation 2026; 12(5) doi: 10.3390/fermentation12050249
|
| 38 |
Alexa C B Johnson, Heidi A Rossow. Effects of two equine digestive aid supplements on hindgut health1. Translational Animal Science 2019; 3(1) doi: 10.1093/tas/txy103
|
| 39 |
Eric Wombwell, Mark E Patterson, Bridget Bransteitter, Lisa R Gillen. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection. Clinical Infectious Diseases 2021; 73(9) doi: 10.1093/cid/ciaa808
|
| 40 |
Rodolphe Pontier-Bres, Dorota Czerucka. The probiotic yeast Saccharomyces boulardii CNCM I-745 prevents autophagy in macrophages and epithelial cells infected with Vibrio parahaemolyticus. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1771497
|
| 41 |
Etienne Labussière, Caroline Achard, Serge Dubois, Sylvie Combes, Mathieu Castex, David Renaudeau. Saccharomyces cerevisiae boulardiiCNCM I-1079 supplementation in finishing male pigs helps to cope with heat stress through feeding behaviour and gut microbiota modulation. British Journal of Nutrition 2022; 127(3) doi: 10.1017/S0007114521001756
|
| 42 |
María Velasco, Teresa Requena, Alberto Delgado-Iribarren, Carmen Peláez, Carlos Guijarro. Probiotic Yogurt for the Prevention of Antibiotic-associated Diarrhea in Adults. Journal of Clinical Gastroenterology 2019; 53(10) doi: 10.1097/MCG.0000000000001131
|
| 43 |
Yifei Li, Ilyas Ali, Zhiqi Lei, Yanan Li, Min Yang, Caixia Yang, Lian Li. Effect of a Multistrain Probiotic on Feline Gut Health through the Fecal Microbiota and Its Metabolite SCFAs. Metabolites 2023; 13(2) doi: 10.3390/metabo13020228
|
| 44 |
Ibrahim Farhani, Ahad Yamchi, Hamid Madanchi, Vahid Khazaei, Mehdi Behrouzikhah, Hamidreza Abbasi, Mohammad Salehi, Nilufar Moradi, Samira Sanami. Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant based
on an Immunoinformatics Approach. Current Computer-Aided Drug Design 2024; 20(3) doi: 10.2174/1573409919666230612125440
|
| 45 |
Jin-Pei Dong, Yue Zheng, Ting Wu, Qun He, Gui-Gen Teng, Hua-Hong Wang. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice. Chinese Medical Journal 2019; 132(16) doi: 10.1097/CM9.0000000000000364
|
| 46 |
Sara Khosravi, Razieh Amini, Mohammad Reza Arabestani, Seyed Saman Talebi, Farid Azizi Jalilian. Isolation of a lytic bacteriophage for Helicobacter pylori. Gene Reports 2021; 23 doi: 10.1016/j.genrep.2021.101107
|
| 47 |
Ankita Thakur, Priyanka Sharma, Arti Jamwal Sharma, Nisha Sharma, Somvir Singh, Navneeti Chamoli, Rajeev Kumar. Probiotics: microbes for human health and beyond. Food Materials Research 2025; 5(1) doi: 10.48130/fmr-0024-0029
|
| 48 |
Qin Chen, Mingliang Zhong, Ye Lin. Exploring gut microbiota and spinal cord injury: pathogenesis, treatment strategies and prospects. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1693883
|
| 49 |
Yongrong Zhang, Ashley Saint Fleur, Hanping Feng.
The development of live biotherapeutics against
Clostridioides difficile
infection towards reconstituting gut microbiota
. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2052698
|
| 50 |
Vikash Kumar, Lucky Gupta, Saurabh Singh, Nikhil Raghuvanshi, Lokesh Sisodiya. Microbial Consortia in Plant Science and Sustainable Agriculture. 2025; doi: 10.1002/9781394325009.ch15
|
| 51 |
Flaviano S. Martins, Angélica T. Vieira, Samir D.A. Elian, Rosa M.E. Arantes, Fabiana C.P. Tiago, Lirlândia P. Sousa, Helena R.C. Araújo, Paulo F. Pimenta, Cláudio A. Bonjardim, Jacques R. Nicoli, Mauro M. Teixeira. Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice. Microbes and Infection 2013; 15(4) doi: 10.1016/j.micinf.2012.12.007
|
| 52 |
Sylvia Cruchet, Raquel Furnes, Aldo Maruy, Eduardo Hebel, Jorge Palacios, Fernando Medina, Nelson Ramirez, Marina Orsi, Lysette Rondon, Vera Sdepanian, Luis Xóchihua, Manuel Ybarra, Roberto Arturo Zablah. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts. Pediatric Drugs 2015; 17(3) doi: 10.1007/s40272-015-0124-6
|
| 53 |
Ming Li, Lin Zhu, Ao Xie, Jieli Yuan. Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition. Inflammation 2015; 38(1) doi: 10.1007/s10753-014-0019-7
|
| 54 |
Joyjyoti Das, Biswa Kalyan Maiti, Samridhi Bhattacharjee, Rishita Rakshit, Bidisha Ray, Rohan Karmakar, Madhumita Patel, Bandana Padhan. Advances in Probiotic Delivery Systems. 2025; doi: 10.1016/B978-0-443-27594-4.00023-1
|
| 55 |
Jason C. Sniffen, Lynne V. McFarland, Charlesnika T. Evans, Ellie J. C. Goldstein, Leandro Araujo Lobo. Choosing an appropriate probiotic product for your patient: An evidence-based practical guide. PLOS ONE 2018; 13(12) doi: 10.1371/journal.pone.0209205
|
| 56 |
Anne Danieli Nascimento Soares, Samuel Penna Wanner, Elissa Stefane Silva Morais, Alexandre Sérvulo Ribeiro Hudson, Flaviano Santos Martins, Valbert Nascimento Cardoso. Supplementation with Saccharomyces boulardii Increases the Maximal Oxygen Consumption and Maximal Aerobic Speed Attained by Rats Subjected to an Incremental-Speed Exercise. Nutrients 2019; 11(10) doi: 10.3390/nu11102352
|
| 57 |
Jang Eun Lee, Eunjung Lee. The Probiotic Effects of the Saccharomyces cerevisiae 28-7 Strain Isolated from Nuruk in a DSS-Induced Colitis Mouse Model. Journal of Microbiology and Biotechnology 2022; 32(7) doi: 10.4014/jmb.2206.06035
|
| 58 |
Jean-Charles Delchier, Fernand Vicari. Hp à l’UEGW d’Amsterdam 2012. Hegel 2012; (4) doi: 10.4267/2042/48720
|
| 59 |
Mathias L. Richard, Bruno Lamas, Giuseppina Liguori, Thomas W. Hoffmann, Harry Sokol. Gut Fungal Microbiota. Inflammatory Bowel Diseases 2015; 21(3) doi: 10.1097/MIB.0000000000000261
|
| 60 |
Bruna Trindade de Carvalho, Ana Subotić, Paul Vandecruys, Sara Deleu, Séverine Vermeire, Johan M. Thevelein, Yvonne Nygård.
Enhancing probiotic impact: engineering
Saccharomyces boulardii
for optimal acetic acid production and gastric passage tolerance
. Applied and Environmental Microbiology 2024; 90(6) doi: 10.1128/aem.00325-24
|
| 61 |
Jorge M.B. Vítor, Filipa F. Vale. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunology & Medical Microbiology 2011; 63(2) doi: 10.1111/j.1574-695X.2011.00865.x
|
| 62 |
Aleksandr V. Gorelov, Irina N. Zakharova, Anatolii I. Khavkin, Liudmila I. Kafarskaya, Denis V. Usenko, Sergei V. Belmer, Elena A. Kornienko, Valerii F. Privorotsky, Viktor V. Krasnov, Elena G. Kondyurina, Viktoriia N. Panfilova, Nafiset Kh. Tkhakushinova, Anna N. Plaksina, Olga A. Rychkova, Dmitrii V. Pechkurov, Aleksandr A. Nizhevich, Rezeda A. Fayzullina, Ekaterina A. Yablokova. Resolution of the Council of Experts “Dysbiosis. Immediate and long-term consequences of microbiome disorders and options for their correction with probiotics”. Pediatrics. Consilium Medicum 2022; (1) doi: 10.26442/26586630.2022.1.201535
|
| 63 |
Paul M. Coates, Holly Nicastro, John A. Milner. Present Knowledge in Nutrition. 2012; doi: 10.1002/9781119946045.ch73
|
| 64 |
Ashima Vohra, Poonam Syal, Anshu Madan. Probiotic yeasts in livestock sector. Animal Feed Science and Technology 2016; 219 doi: 10.1016/j.anifeedsci.2016.05.019
|
| 65 |
Hassan Seddik, Hanae Boutallaka, Ilham Elkoti, Fouad Nejjari, Reda Berraida, Sanaa Berrag, Khaoula Loubaris, Sara Sentissi, Ahmed Benkirane. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial. European Journal of Clinical Pharmacology 2019; 75(5) doi: 10.1007/s00228-019-02625-0
|
| 66 |
Imen Fguiri, Manel Ziadi, Samira Arroum, Touhami Khorchani, Hammadi Mohamed. Probiotic Potential and Characterization of Enterococcus faecium Strains Isolated from Camel Milk: Implications for Animal Health and Dairy Products. Fermentation 2025; 11(8) doi: 10.3390/fermentation11080444
|
| 67 |
Gerald Friedman. The Role of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea and Clostridium Difficile Colitis. Gastroenterology Clinics of North America 2012; 41(4) doi: 10.1016/j.gtc.2012.08.002
|
| 68 |
Zhiyuan Hao, Yiting Lu, Yarong Hao, Yuanyuan Luo, Kaiming Wu, Changpeng Zhu, Peimei Shi, Feng Zhu, Yong Lin, Xin Zeng. Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis. Journal of Gastroenterology 2025; 60(3) doi: 10.1007/s00535-024-02183-y
|
| 69 |
Mickaël Alain Fleury, Olivier Le Goff, Sylvain Denis, Frédérique Chaucheyras-Durand, Eric Jouy, Isabelle Kempf, Monique Alric, Stéphanie Blanquet-Diot. Development and validation of a new dynamic in vitro model of the piglet colon (PigutIVM): application to the study of probiotics. Applied Microbiology and Biotechnology 2017; 101(6) doi: 10.1007/s00253-017-8122-y
|
| 70 |
Monique M Elseviers, Yoleen Van Camp, Sander Nayaert, Khyra Duré, Lieven Annemans, Ann Tanghe, Sebastian Vermeersch. Prevalence and management of antibiotic associated diarrhea in general hospitals. BMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0869-0
|
| 71 |
Gerard Mullin. Gastrointestinal and Liver Disease Nutrition Desk Reference. 2011; doi: 10.1201/b11184-4
|
| 72 |
S. Lital Meyer, A. Ricardo Espinoza, P. Rodrigo Quera. Infección por clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas. Revista Médica Clínica Las Condes 2014; 25(3) doi: 10.1016/S0716-8640(14)70064-1
|
| 73 |
H. Szajewska, A. Horvath, A. Piwowarczyk. Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Alimentary Pharmacology & Therapeutics 2010; 32(9) doi: 10.1111/j.1365-2036.2010.04457.x
|
| 74 |
Jing Ji, Tiange Li, Baoying Ma, Runzhong Wang. A Bifidobacterium Strain with Antibacterial Activity, Its Antibacterial Characteristics and In Vitro Probiotics Studies. Microorganisms 2025; 13(6) doi: 10.3390/microorganisms13061190
|
| 75 |
Nyier W Doar, Shamini D Samuthiram. Qualitative Analysis of the Efficacy of Probiotic Strains in the Prevention of Antibiotic-Associated Diarrhea. Cureus 2023; doi: 10.7759/cureus.40261
|
| 76 |
Ivana Repić, Nina Čuljak, Matea Hrupački, Iva Čanak, Ksenija Markov, Jadranka Frece. Novel Skin- and Oral-Derived Probiotic Candidates: Functional Evaluation and Application Perspectives. Microorganisms 2026; 14(2) doi: 10.3390/microorganisms14020385
|
| 77 |
Carlos Jadán-Piedra, Marta Baquedano, Sergi Puig, Dinoraz Vélez, Vicenta Devesa. Use of Saccharomyces cerevisiae To Reduce the Bioaccessibility of Mercury from Food. Journal of Agricultural and Food Chemistry 2017; 65(13) doi: 10.1021/acs.jafc.7b00285
|
| 78 |
Lorenzo Morelli, Maria Luisa Callegari. Metabolic Syndrome and Complications of Pregnancy. 2015; doi: 10.1007/978-3-319-16853-1_3
|
| 79 |
Daiane Costa dos Santos, Josemar Gonçalves de Oliveira Filho, Juliana Risso Andretta, Fabiano Guimarães Silva, Mariana Buranelo Egea. Challenges in maintaining the probiotic potential in alcoholic beverage development. Food Bioscience 2023; 52 doi: 10.1016/j.fbio.2023.102485
|
| 80 |
Mehran Mahooti, Fatemeh Safaei, Zahra Mousavian, Avisha Samimiazad, Maliheh Bakhtiyarizadeh, Ali Emadi, Leyla Babae, Forouh Sadat Hassani, Alaleh Eskandari, Ezzat Mohamad Azman, Davood Zare. Potential of yeast probiotics as immunomodulators: a new frontier in cancer management. Future Microbiology 2026; 21(1) doi: 10.1080/17460913.2026.2624283
|
| 81 |
Marie Ceccarelli, Vanessa Gouyot, Olivier Marty. Endométriose. 2020; doi: 10.1016/B978-2-294-76781-4.00018-1
|
| 82 |
R. Ann Hays, Christina Surawicz. Geriatric Gastroenterology. 2021; doi: 10.1007/978-3-030-30192-7_71
|
| 83 |
Mario Matijašić, Tomislav Meštrović, Hana Čipčić Paljetak, Mihaela Perić, Anja Barešić, Donatella Verbanac. Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. International Journal of Molecular Sciences 2020; 21(8) doi: 10.3390/ijms21082668
|
| 84 |
Joseph H Collins, Lohith Kunyeit, Sarah Weintraub, Nilesh Sharma, Charlotte White, Nabeeha Haq, K A Anu-Appaiah, Reeta P Rao, Eric M Young, N Whiteman. Genetic basis for probiotic yeast phenotypes revealed by nanopore sequencing. G3: Genes, Genomes, Genetics 2023; 13(8) doi: 10.1093/g3journal/jkad093
|
| 85 |
Christina Prather, Mariatu Koroma-Nelson, Mikhail Kogan. Integrative Geriatric Medicine. 2017; doi: 10.1093/med/9780190466268.003.0017
|
| 86 |
Kerry L Ivey, Jonathan M Hodgson, Susan W Kim, Richard J Woodman, Richard L Prince. Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adults. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD010445.pub2
|
| 87 |
Emily M. Mercer, Marie-Claire Arrieta. Probiotics to improve the gut microbiome in premature infants: are we there yet?. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2201160
|
| 88 |
L. V. McFarland. From Yaks to Yogurt: The History, Development, and Current Use of Probiotics. Clinical Infectious Diseases 2015; 60(suppl 2) doi: 10.1093/cid/civ054
|
| 89 |
Paola Brun, Melania Scarpa, Chiara Marchiori, Gloria Sarasin, Valentina Caputi, Andrea Porzionato, Maria Cecilia Giron, Giorgio Palù, Ignazio Castagliuolo, Seungil Ro. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0181863
|
| 90 |
R. Ann Hays, Christina Surawicz. Geriatric Gastroenterology. 2020; doi: 10.1007/978-3-319-90761-1_71-1
|
| 91 |
Taylor C Wallace, Francisco Guarner, Karen Madsen, Michael D Cabana, Glenn Gibson, Eric Hentges, Mary Ellen Sanders. Human gut microbiota and its relationship to health and disease. Nutrition Reviews 2011; 69(7) doi: 10.1111/j.1753-4887.2011.00402.x
|
| 92 |
Samara Rocha Mendes dos Santos, William Cristiane Teles Tonini, Ricardo Luís Wagner, Antônio do Nascimento, Keisyara Bonfim dos Santos, Thalis Thalis Alves Nogueira, Wenderson Nascimento Bessa, Ubiratan Ferreira da Cruz. INFLUÊNCIA DE LEVEDURA (SACCHAROMYCES BOULARDII) NO DESEMPENHO ZOOTÉCNICO DE TILÁPIA- DO- NILO (OREOCHROMIS NILOTICUS), ALIMENTADA COM DIETA SUPLEMENTADA COM PALMA (OPUNTIA FICUS-INDICA). Revista Brasileira de Engenharia de Pesca 2026; 17(1) doi: 10.18817/repesca.v17i1.2155
|
| 93 |
Fahimeh Ghanbari, Samira Hasani, Zahra Sadat Aghili, Sedigheh Asgary. The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review. Food Science & Nutrition 2024; 12(7) doi: 10.1002/fsn3.4142
|
| 94 |
Samuele Voyron, Francesca Bietto, Mauro Fontana, Elisa Martello, Natascia Bruni, Enrica Pessione. Molecular Characterization of the Gorgonzola Cheese Mycobiota and Selection of a Putative Probiotic Saccharomyces cerevisiae var. boulardii for Evaluation as a Veterinary Feed Additive. Applied Microbiology 2024; 4(2) doi: 10.3390/applmicrobiol4020045
|
| 95 |
Hannah Elena Duffey, Karl Alex Hedin, Hitesh P. Gelli, Troels Holger Vaaben, Morten Otto Alexander Sommer. Genomic and phenotypic comparisons reveal lineage-specific traits of the probiotic Saccharomyces boulardii. iScience 2026; 29(5) doi: 10.1016/j.isci.2026.115706
|
| 96 |
Mario Zucca, Sara Scutera, Dianella Savoia. Novel avenues forClostridium difficileinfection drug discovery. Expert Opinion on Drug Discovery 2013; 8(4) doi: 10.1517/17460441.2013.770466
|
| 97 |
Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.776955
|
| 98 |
Lingfen Xu, Yun Wang, Yang Wang, Jianhua Fu, Mei Sun, Zhiqin Mao, Yvan Vandenplas. A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants. Jornal de Pediatria 2016; 92(3) doi: 10.1016/j.jped.2015.08.013
|
| 99 |
Lynne V. McFarland, Tong Li. Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1587792
|
| 100 |
Christopher L. Knight, Christina M. Surawicz. Clostridium difficile Infection. Medical Clinics of North America 2013; 97(4) doi: 10.1016/j.mcna.2013.02.003
|
| 101 |
Igor V. Maev, Dmitry N. Andreev, Rafik I. Shaburov, Andrey V. Zaborovsky, Alexey K. Fomenko, Philipp S. Sokolov, Sergey V. Tsaregorodtsev, Mikhail K. Devkota, Diana T. Dicheva, Sergey V. Cheremushkin, Natalya V. Cheremushkinа, Artem V. Vychkin. Study on the efficacy of combination therapy with rifaximin and <i>Saccharomyces boulardii</i> CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors. Terapevticheskii arkhiv 2025; 97(8) doi: 10.26442/00403660.2025.08.203301
|
| 102 |
Garima Mishra, Pradeep Singh, Mulugeta Molla, Yohannes Shumet Yimer, Subas Chandra Dinda, Phool Chandra, Bhuvnesh Kumar Singh, Samuel Berihun Dagnew, Abraham Nigussie Assefa, Amien Ewunetie. Harnessing the potential of probiotics in the treatment of alcoholic liver disorders. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212742
|
| 103 |
L.V. McFarland. The Microbiota in Gastrointestinal Pathophysiology. 2017; doi: 10.1016/B978-0-12-804024-9.00018-5
|
| 104 |
Gerard E. Mullin. Probiotics and Digestive Disease. Nutrition in Clinical Practice 2012; 27(2) doi: 10.1177/0884533612439609
|
| 105 |
Filipa F. Vale, Jorge M. B. Vítor, Mónica Oleastro. Helicobacter pylori Research. 2016; doi: 10.1007/978-4-431-55936-8_24
|
| 106 |
Jiaojiao Xie, Mingfei Yao, Yanmeng Lu, Mengjia Yu, Shengyi Han, David J. McClements, Hang Xiao, Lanjuan Li. Impact of encapsulating a probiotic (Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infections. Food & Function 2021; 12(7) doi: 10.1039/D0FO03235B
|
| 107 |
Viet Anh Vu, Chreng Lis, Da-Hye Kim, Yong-Suk Lee, Kyung-Woo Lee. Role of Dietary Saccharomyces boulardii in Innate Immune Responses of Broiler Chickens Fed Diets Containing Different Nutrient Densities. Animals 2025; 15(23) doi: 10.3390/ani15233425
|
| 108 |
Bradley C Johnston, Joshua Z Goldenberg, Per O Vandvik, Xin Sun, Gordon H Guyatt, Bradley C Johnston. Cochrane Database of Systematic Reviews. 2011; doi: 10.1002/14651858.CD004827.pub3
|
| 109 |
Margret I Moré, Yvan Vandenplas. Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review. Clinical Medicine Insights: Gastroenterology 2018; 11 doi: 10.1177/1179552217752679
|
| 110 |
Matheus A. S. Santos, Mariana T. C. Machado. Coated alginate–chitosan particles to improve the stability of probiotic yeast. International Journal of Food Science & Technology 2021; 56(5) doi: 10.1111/ijfs.14829
|
| 111 |
Mathias L. Richard, Harry Sokol. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nature Reviews Gastroenterology & Hepatology 2019; doi: 10.1038/s41575-019-0121-2
|
| 112 |
Annie G. West, Andrew Digby, Michael W. Taylor. The mycobiota of faeces from the critically endangered kākāpō and associated nest litter. New Zealand Journal of Zoology 2025; 52(2) doi: 10.1080/03014223.2023.2170428
|
| 113 |
Grégoire Wieërs, Leila Belkhir, Raphaël Enaud, Sophie Leclercq, Jean-Michel Philippart de Foy, Isabelle Dequenne, Philippe de Timary, Patrice D. Cani. How Probiotics Affect the Microbiota. Frontiers in Cellular and Infection Microbiology 2020; 9 doi: 10.3389/fcimb.2019.00454
|
| 114 |
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017; 82(2) doi: 10.1016/j.rgmxen.2017.03.003
|
| 115 |
Kwang-Rim Baek, Hyun-Ji Lee, Kang-Hyeon Jeong, Bo-Ram Park, Soo-Jung Kim, Seung-Oh Seo. Parabiotic immunomodulatory activity of yeast cell wall polysaccharides from Saccharomyces cerevisiae and S. boulardii. Journal of Functional Foods 2024; 123 doi: 10.1016/j.jff.2024.106577
|
| 116 |
Seema Patel. Nutrition, safety, market status quo appraisal of emerging functional food corn smut (huitlacoche). Trends in Food Science & Technology 2016; 57 doi: 10.1016/j.tifs.2016.09.006
|
| 117 |
Karina Nascimento Pereira, Amanda Cristina Dias de Oliveira, Handray Fernandes de Souza, Sana Ullah, Usama Nasir, Sher Ali, Carlos Augusto Fernandes de Oliveira. Application of Saccharomyces cerevisiae var. boulardii for Biological Detoxification of Chemical Contaminants in Foods: A Comprehensive Review. Foods 2025; 14(24) doi: 10.3390/foods14244260
|
| 118 |
Denisa Margină, Carmen Purdel. Encyclopedia of Toxicology. 2024; doi: 10.1016/B978-0-12-824315-2.00089-0
|
| 119 |
|
| 120 |
Mati Ullah, Muhammad Rizwan, Ali Raza, Yutong Xia, Jianda Han, Yi Ma, Huayou Chen. Snapshot of the Probiotic Potential of Kluveromyces marxianus DMKU-1042 Using a Comparative Probiogenomics Approach. Foods 2023; 12(23) doi: 10.3390/foods12234329
|
| 121 |
Rong Zhu, Kan Chen, Yuan-Yuan Zheng, Hua-Wei Zhang, Jun-Shan Wang, Yu-Jing Xia, Wei-Qi Dai, Fan Wang, Miao Shen, Ping Cheng, Yan Zhang, Cheng-Fen Wang, Jing Yang, Jing-Jing Li, Jie Lu, Ying-Qun Zhou, Chuan-Yong Guo. Meta-analysis of the efficacy of probiotics in <italic>Helicobacter pylori</italic> eradication therapy. World Journal of Gastroenterology 2014; 20(47): 18013-18021 doi: 10.3748/wjg.v20.i47.18013
|
| 122 |
Nicanor Austriaco. Yeast oral vaccines against infectious diseases. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1150412
|
| 123 |
Jing Yu, Chen Cui, Kai Ma, Peng Yang, Yizhou Jiang, Xiaoyong Wang. Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03524-0
|
| 124 |
Mustafa Türker, Ümit Cem Derman, Filiz Alemdar. Eukaryotic Microorganisms as Sources of Bioproducts. 2025; doi: 10.1016/B978-0-443-30188-9.00011-1
|
| 125 |
Sarah M Schmid, M Katherine Tolbert. Harnessing the microbiome: probiotics, antibiotics and their role in canine and feline gastrointestinal disease. Veterinary Record 2024; 195(S2) doi: 10.1002/vetr.4915
|
| 126 |
|
| 127 |
Satyajit Lenka, Deepak Singh, Sandip Paul, Anindita Gayen, Manabendra Chandra. S. boulardii Fails to Hold Its Cell Wall Integrity against Nonpathogenic E. coli: Are Probiotic Yeasts Losing the Battle?. ACS Infectious Diseases 2021; 7(4) doi: 10.1021/acsinfecdis.0c00413
|
| 128 |
E.C. Dinleyici, A. Kara, N. Dalgic, Z. Kurugol, V. Arica, O. Metin, E. Temur, O. Turel, S. Guven, O. Yasa, S. Bulut, G. Tanir, A.S. Yazar, A. Karbuz, M. Sancar, M. Erguven, G. Akca, M. Eren, M. Ozen, Y. Vandenplas. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea. Beneficial Microbes 2015; 6(4) doi: 10.3920/BM2014.0086
|
| 129 |
Marcela Moreira Terhaag, Otávio Akira Sakai, Fabiana Ruiz, Sandra Garcia, Fernando Rodrigo Bertusso, Sandra Helena Prudêncio. The Probiotication of a Lychee Beverage with Saccharomyces boulardii: An Alternative to Dairy-Based Probiotic Products. Foods 2025; 14(2) doi: 10.3390/foods14020156
|
| 130 |
Erick Manuel Toro Monjaraz, Karen Rubí Ignorosa Arellano, Alejandro Loredo Mayer, Berenice Palacios-González, Roberto Cervantes Bustamante, Jaime Alfonso Ramírez Mayans. Gut Microbiota in Mexican Children With Acute Diarrhea. Pediatric Infectious Disease Journal 2021; 40(8) doi: 10.1097/INF.0000000000003128
|
| 131 |
Yihang Chen, Liukun Meng, Wen Yuan, Zehan Gao, Xun Zhang, Boqia Xie, Jiawei Song, Jifeng Li, Jiuchang Zhong, Xiaoyan Liu. Gut Fungal Microbiota Alterations in Pulmonary Arterial Hypertensive Rats. Biomedicines 2024; 12(2) doi: 10.3390/biomedicines12020298
|
| 132 |
Sunita Grover, Rashmi H. Mallappa, Virender Kumar Batish. Encyclopedia of Metagenomics. 2014; doi: 10.1007/978-1-4614-6418-1_575-2
|
| 133 |
Alyssa M. Parian, Berkeley N. Limketkai, Neha D. Shah, Gerard E. Mullin. Nutraceutical Supplements for Inflammatory Bowel Disease. Nutrition in Clinical Practice 2015; 30(4) doi: 10.1177/0884533615586598
|
| 134 |
Deewakar Baral, Aditi Kaushik. Fungicide toxicity and Alternatives: The emerging role of biocontrol yeasts in food safety and human health safeguarding. Food Bioscience 2025; 74 doi: 10.1016/j.fbio.2025.107922
|
| 135 |
Aafrin Waziri, Charu Bharti, Mohammed Aslam, Parween Jamil, Mohd. Aamir Mirza, Md Noushad Javed, Uzma Pottoo, Amirhossein Ahmadi, Md Sabir Alam. Probiotics for the Chemoprotective Role against the Toxic Effect of Cancer Chemotherapy. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(4) doi: 10.2174/1871520621666210514000615
|
| 136 |
L.R. Hancox, M. Le Bon, P.J. Richards, D. Guillou, C.E.R. Dodd, K.H. Mellits. Effect of a single dose of Saccharomyces cerevisiae var. boulardii on the occurrence of porcine neonatal diarrhoea. Animal 2015; 9(11) doi: 10.1017/S1751731114002687
|
| 137 |
H. Szajewska, M. Kołodziej. Systematic review with meta‐analysis: Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea. Alimentary Pharmacology & Therapeutics 2015; 42(7) doi: 10.1111/apt.13344
|
| 138 |
Ozgenur Hacioglu. Microbial World: Bacteria and Archaea. Progress in Molecular and Subcellular Biology 2026; 62 doi: 10.1007/978-3-032-11438-9_9
|
| 139 |
Rodolphe Pontier-Bres, Dorota Czerucka. Saccharomyces boulardii CNCM I-745 Stimulates Intracellular Antimicrobial Activity Against Salmonella Typhimurium in Murine Macrophages. Microorganisms 2026; 14(4) doi: 10.3390/microorganisms14040787
|
| 140 |
Gyu Man Oh, Won Moon, Kwang Il Seo, Kyoungwon Jung, Jae Hyun Kim, Sung Eun Kim, Moo In Park, Seun Ja Park. Changes in the Crohn’s Disease Activity Index and Safety of Administering Saccharomyces Boulardii in Patients with Crohn’s Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort Study. The Korean Journal of Gastroenterology 2020; 76(6) doi: 10.4166/kjg.2020.115
|
| 141 |
Le Chen, Yan Wang, Xiao Liu, Haioun Wong, Chengjiao Huang. Probiotics for pediatric diarrhea and constipation: an umbrella meta-analysis. BMC Pediatrics 2025; 25(1) doi: 10.1186/s12887-025-06002-y
|
| 142 |
Fernanda Cosme, António Inês, Alice Vilela. Consumer’s acceptability and health consciousness of probiotic and prebiotic of non-dairy products. Food Research International 2022; 151 doi: 10.1016/j.foodres.2021.110842
|
| 143 |
Ozge Serce, Derya Benzer, Tugba Gursoy, Guner Karatekin, Fahri Ovali. Efficacy of saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: A randomised controlled trial. Early Human Development 2013; 89(12) doi: 10.1016/j.earlhumdev.2013.08.013
|
| 144 |
Karen Madsen. The International Scientific Conference on Probiotics and Prebiotics. Expert Review of Gastroenterology & Hepatology 2011; 5(5) doi: 10.1586/egh.11.61
|
| 145 |
Roman Maslennikov, Nona Benuni, Anna Levshina, Farida Adzhieva, Tatyana Demina, Alina Kucher, Ekaterina Pervushova, Evgeniya Yuryeva, Elena Poluektova, Oxana Zolnikova, Evgenii Kozlov, Alexey Sigidaev, Vladimir Ivashkin. Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review. Microorganisms 2024; 12(8) doi: 10.3390/microorganisms12081678
|
| 146 |
Wenjie Zhang, Jie Zhang, Tian Liu, Juan Xing, Huan Zhang, Daorong Wang, Dong Tang. Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention. Journal of Cancer Research and Clinical Oncology 2022; 148(9) doi: 10.1007/s00432-022-04081-3
|
| 147 |
Lynne V McFarland. Emerging therapies forClostridium difficileinfections. Expert Opinion on Emerging Drugs 2011; 16(3) doi: 10.1517/14728214.2011.571204
|
| 148 |
Lorena Vívien Neves de Oliveira, Rafael Wesley Bastos, Noelly de Queiroz Ribeiro, Marliete Carvalho Costa, Leonardo Borges Acurcio, Karen Maia Rocha, Julliana Ribeiro Alves Santos, Rosana de Carvalho Cruz, Betânia Maria Soares, Daniel Assis Santos. In vivo probiotic and antimicrobial photodynamic therapy as alternative therapies against cryptococcosis are ineffective. Veterinary Microbiology 2017; 211 doi: 10.1016/j.vetmic.2017.08.015
|
| 149 |
Priscilla F. C. Justino, Luis F. M. Melo, Andre F. Nogueira, Jose V. G. Costa, Luara M. N. Silva, Cecila M. Santos, Walber O. Mendes, Marina R. Costa, Alvaro X. Franco, Aldo A. Lima, Ronaldo A. Ribeiro, Marcellus H. L. P. Souza, Pedro M. G. Soares. Treatment withSaccharomyces boulardiireduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice. British Journal of Nutrition 2014; 111(9) doi: 10.1017/S0007114513004248
|
| 150 |
Amandine Everard, Sébastien Matamoros, Lucie Geurts, Nathalie M. Delzenne, Patrice D. Cani, Martin J. Blaser.
Saccharomyces boulardii
Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low
-
Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic
db
/
db
Mice
. mBio 2014; 5(3) doi: 10.1128/mBio.01011-14
|
| 151 |
Lauren E. Hudson, Milo B. Fasken, Courtney D. McDermott, Shonna M. McBride, Emily G. Kuiper, David B. Guiliano, Anita H. Corbett, Tracey J. Lamb, Alvaro Galli. Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii. PLoS ONE 2014; 9(11) doi: 10.1371/journal.pone.0112660
|
| 152 |
P. Trevisi, R. Latorre, D. Priori, D. Luise, I. Archetti, M. Mazzoni, R. D’Inca, P. Bosi. Effect of feed supplementation with live yeast on the intestinal transcriptome profile of weaning pigs orally challenged with Escherichia coli F4. Animal 2017; 11(1) doi: 10.1017/S1751731116001178
|
| 153 |
Pierre-Alexandre Lacotte, Alexis Simons, Sylvie Bouttier, Jeanne Malet-Villemagne, Valérie Nicolas, Claire Janoir. Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition. Microorganisms 2022; 10(6) doi: 10.3390/microorganisms10061082
|
| 154 |
Madhu S. Malo, Omeed Moaven, Nur Muhammad, Brishti Biswas, Sayeda N. Alam, Konstantinos P. Economopoulos, Sarah Shireen Gul, Sulaiman R. Hamarneh, Nondita S. Malo, Abeba Teshager, Mussa M. Rafat Mohamed, Qingsong Tao, Sonoko Narisawa, José Luis Millán, Elizabeth L. Hohmann, H. Shaw Warren, Simon C. Robson, Richard A. Hodin. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 306(10) doi: 10.1152/ajpgi.00357.2013
|
| 155 |
Jonathan Thévenot, Lucie Etienne-Mesmin, Sylvain Denis, Sandrine Chalancon, Monique Alric, Valérie Livrelli, Stéphanie Blanquet-Diot.
Enterohemorrhagic Escherichia coli O157:H7 Survival in an
In Vitro
Model of the Human Large Intestine and Interactions with Probiotic Yeasts and Resident Microbiota
. Applied and Environmental Microbiology 2013; 79(3) doi: 10.1128/AEM.03303-12
|
| 156 |
Lingfen Xu, Yun Wang, Yang Wang, Jianhua Fu, Mei Sun, Zhiqin Mao, Yvan Vandenplas. A double‐blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I‐745 in formula‐fed preterm infants. Jornal de Pediatria (Versão em Português) 2016; 92(3) doi: 10.1016/j.jpedp.2016.03.004
|
| 157 |
Alice Vilela, Fernanda Cosme, António Inês. Wine and Non-Dairy Fermented Beverages: A Novel Source of Pro- and Prebiotics. Fermentation 2020; 6(4) doi: 10.3390/fermentation6040113
|
| 158 |
Nooshin Naghibzadeh, Fatemeh Salmani, Samira Nomiri, Tahmine Tavakoli. Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02187-z
|
| 159 |
Mariarosaria Matera, Valentina Biagioli, Stefano Leo, Lorenzo Drago. Probiotics and Antibiotics: From Empirical Practice to a Biological Rationale for Targeted Choice During Antibiotic Therapy. Microorganisms 2026; 14(4) doi: 10.3390/microorganisms14040763
|
| 160 |
Wendy Franco. Postbiotics and parabiotics derived from bacteria and yeast: current trends and future perspectives. CyTA - Journal of Food 2024; 22(1) doi: 10.1080/19476337.2024.2425838
|
| 161 |
Qin Guo, Joshua Z Goldenberg, Claire Humphrey, Regina El Dib, Bradley C Johnston. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD004827.pub5
|
| 162 |
A. G. Boyle, K. G. Magdesian, R. Gallop, S. Sigdel, M. M. Durando. Saccharomyces boulardii viability and efficacy in horses with antimicrobial‐induced diarrhoea. Veterinary Record 2013; 172(5) doi: 10.1136/vr.100833
|
| 163 |
Ding-Ni Qu, Ze-Xuan Ji, Jun-Qi Zhang, Xiao-Yong Wang. Vonoprazan–Amoxicillin Dual Therapy with or Without Saccharomyces boulardii Supplementation as a Rescue Regimen for Helicobacter pylori Infection. Infection and Drug Resistance 2026; doi: 10.2147/IDR.S594118
|
| 164 |
Dina Yousif, Yan Wu, Alexandria Azul Gonzales, Christa Mathieu, Yan Zeng, Lee Sample, Sabrina Terando, Ting Li, Jin Xiao. Anti-Cariogenic Effects of S. cerevisiae and S. boulardii in S. mutans–C. albicans Cross-Kingdom In Vitro Models. Pharmaceutics 2024; 16(2) doi: 10.3390/pharmaceutics16020215
|
| 165 |
Nancy Awasti, Santosh Anand. Dairy Processing: Advanced Research to Applications. 2020; doi: 10.1007/978-981-15-2608-4_12
|
| 166 |
Abhijit Banik, Joy Mondal, Subham Rakshit, Kuntal Ghosh, Shankar Prasad Sha, Suman Kumar Halder, Chandradipa Ghosh, Keshab Chandra Mondal. Amelioration of cold-induced gastric injury by a yeast probiotic isolated from traditional fermented foods. Journal of Functional Foods 2019; 59 doi: 10.1016/j.jff.2019.05.039
|
| 167 |
Jia Li, Shuwei Pei, Lu Feng, Jiangyun Liu, Qiwen Zheng, Xingrong Liu, Ye Ruan, Weigang Hu, Li Zhang, Jingping Niu, Tian Tian. Effects of Long-Term Heavy Metal Exposure on the Species Diversity, Functional Diversity, and Network Structure of Oral Mycobiome. Microorganisms 2025; 13(3) doi: 10.3390/microorganisms13030622
|
| 168 |
Ener Cagri Dinleyici, Makbule Eren, Metehan Ozen, Zeynel Abidin Yargic, Yvan Vandenplas. Effectiveness and safety ofSaccharomyces boulardiifor acute infectious diarrhea. Expert Opinion on Biological Therapy 2012; 12(4) doi: 10.1517/14712598.2012.664129
|
| 169 |
Gerardo Pio Nardone, Arrigo Francesco Giuseppe Cicero, Luca Gallelli, Roberto Berni Canani. Managing Gut Dysbiosis: Clinical Evidence and Perspectives on Saccharomyces boulardii CNCM I-745 for Diarrhoeal Conditions in Adults and Children. Microorganisms 2026; 14(1) doi: 10.3390/microorganisms14010150
|
| 170 |
Sylwia Dudzicz-Gojowy, Andrzej Więcek, Marcin Adamczak. The Role of Probiotics in the Prevention of Clostridioides difficile Infection in Patients with Chronic Kidney Disease. Nutrients 2024; 16(5) doi: 10.3390/nu16050671
|
| 171 |
The interplay between malnutrition, persistent diarrhea, lactose intolerance, and food associated gut dysbiosis in children; a comprehensive review. BMC Pediatrics 2026; 26(1) doi: 10.1186/s12887-026-06529-8
|
| 172 |
Agnieszka Krawczyk, Dominika Salamon, Kinga Kowalska-Duplaga, Barbara Zapała, Teofila Książek, Marta Drażniuk-Warchoł, Tomasz Gosiewski. Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease. World Journal of Gastroenterology 2023; 29(14): 2172-2187 doi: 10.3748/wjg.v29.i14.2172
|
| 173 |
Kevin Chen, Yixuan Zhu, Yongrong Zhang, Therwa Hamza, Hua Yu, Ashley Saint Fleur, James Galen, Zhiyong Yang, Hanping Feng.
A probiotic yeast-based immunotherapy against
Clostridioides difficile
infection
. Science Translational Medicine 2020; 12(567) doi: 10.1126/scitranslmed.aax4905
|
| 174 |
Sahil Khanna, Darrell S. Pardi. Clostridium difficile infection: management strategies for a difficult disease. Therapeutic Advances in Gastroenterology 2014; 7(2) doi: 10.1177/1756283X13508519
|
| 175 |
Pilar Calo-Mata, Jose Manuel Ageitos, Karola Böhme, Jorge Barros-Velázquez. New Weapons to Control Bacterial Growth. 2016; doi: 10.1007/978-3-319-28368-5_12
|
| 176 |
K.S. Divya, S. Mahadeva Murthy, Sudisha Jogaiah. Biocontrol Agents and Secondary Metabolites. 2021; doi: 10.1016/B978-0-12-822919-4.00027-2
|
| 177 |
Handray Fernandes de SOUZA, Mariana Fronja CAROSIA, Carolina PINHEIRO, Marina Vieira de CARVALHO, Carlos Augusto Fernandes de OLIVEIRA, Eliana Setsuko KAMIMURA. On probiotic yeasts in food development: Saccharomyces boulardii, a trend. Food Science and Technology 2022; 42 doi: 10.1590/fst.92321
|
| 178 |
Matthew L. Wheeler, Jose J. Limon, David M. Underhill. Immunity to Commensal Fungi: Detente and Disease. Annual Review of Pathology: Mechanisms of Disease 2017; 12(1) doi: 10.1146/annurev-pathol-052016-100342
|
| 179 |
Hannah D. Holscher. Diet Affects the Gastrointestinal Microbiota and Health. Journal of the Academy of Nutrition and Dietetics 2020; 120(4) doi: 10.1016/j.jand.2019.12.016
|
| 180 |
Femke Van Gaever, Paul Vandecruys, Yasmine Driege, Seo Woo Kim, Johan M. Thevelein, Rudi Beyaert, Jens Staal. Multi-step pathway engineering in probiotic Saccharomyces boulardii for abscisic acid production in the gut. Metabolic Engineering Communications 2025; 20 doi: 10.1016/j.mec.2025.e00263
|
| 181 |
C Stevenson, R Blaauw. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 2011; 24(2) doi: 10.1080/16070658.2011.11734353
|
| 182 |
João Paulo Carvalho, David Sáez Moreno, Lucília Domingues. Genetic engineering of Saccharomyces boulardii: Tools, strategies and advances for enhanced probiotic and therapeutic applications. Biotechnology Advances 2025; 84 doi: 10.1016/j.biotechadv.2025.108663
|
| 183 |
Tianyang Wang, Shiwen Zhuang. Probiotic Yeast for Brewing? A Mini-Review of Craft Brewing Research with Saccharomyces cerevisiae var. boulardii. Beverages 2026; 12(5) doi: 10.3390/beverages12050058
|
| 184 |
A. S. Sarsenbaeva, L. B. Lazebnik. Features of intestinal damage in COVID-19. Experimental and Clinical Gastroenterology 2020; (12) doi: 10.31146/1682-8658-ecg-184-12-16-22
|
| 185 |
Morgambal Padayachee, Janicke Visser, Estelle Viljoen, Alfred Musekiwa, Renée Blaauw. Efficacy and safety ofSaccharomyces boulardiiin the treatment of acute gastroenteritis in the paediatric population: a systematic review. South African Journal of Clinical Nutrition 2019; 32(3) doi: 10.1080/16070658.2018.1449378
|
| 186 |
Michał Seweryn Karbownik, Joanna Kręczyńska, Paulina Kwarta, Magdalena Cybula, Anna Wiktorowska-Owczarek, Edward Kowalczyk, Tadeusz Pietras, Janusz Szemraj. Effect of Supplementation with Saccharomyces Boulardii on Academic Examination Performance and Related Stress in Healthy Medical Students: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2020; 12(5) doi: 10.3390/nu12051469
|
| 187 |
Johnathan Sheele, Jessica Cartowski, Angela Dart, Arjun Poddar, Shikha Gupta, Eric Stashko, Bhaskara S. Ravi, Crawford Nelson, Ajay Gupta. Saccharomyces boulardiiand bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera. Pathogens and Global Health 2015; 109(6) doi: 10.1179/2047773215Y.0000000028
|
| 188 |
Meryem KEÇELİ BAŞARAN, Nur Şeyma ZENGİN. Can Saccharomyces boulardii treat and eradicate Helicobacter pylori among children instead of bismuth?. Journal of Health Sciences and Medicine 2022; 5(3) doi: 10.32322/jhsm.1084384
|
| 189 |
Isabella W. Martin, Rita Tonner, Julie Trivedi, Heather Miller, Richard Lee, Xinglun Liang, Leo Rotello, Elena Isenbergh, Jennifer Anderson, Trish Perl, Sean X. Zhang. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use. Diagnostic Microbiology and Infectious Disease 2017; 87(3) doi: 10.1016/j.diagmicrobio.2016.12.004
|
| 190 |
Lena M. Napolitano, Charles E. Edmiston. Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update. Surgery 2017; 162(2) doi: 10.1016/j.surg.2017.01.018
|
| 191 |
|
| 192 |
Mohamed Sageer, Amy Barto. Recurrent Clostridium difficile infection: The scope of the problem and management decisions. Seminars in Colon and Rectal Surgery 2014; 25(3) doi: 10.1053/j.scrs.2014.05.012
|
| 193 |
Katarzyna B. Hooks, Maureen A. O'Malley. Contrasting Strategies: Human Eukaryotic Versus Bacterial Microbiome Research. Journal of Eukaryotic Microbiology 2020; 67(2) doi: 10.1111/jeu.12766
|
| 194 |
Alexandra-Kristine Tonch-Cerbu, Adrian-Gheorghe Boicean, Oana-Maria Stoia, Minodora Teodoru. Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178488
|
| 195 |
Zhang Bin, Xu Ya-Zheng, Deng Zhao-Hui, Chu Bo, Jiang Li-Rong, Yvan Vandenplas. The Efficacy ofSaccharomyces boulardiiCNCM I-745 in Addition to StandardHelicobacter pyloriEradication Treatment in Children. Pediatric Gastroenterology, Hepatology & Nutrition 2015; 18(1) doi: 10.5223/pghn.2015.18.1.17
|
| 196 |
J.F. Garcia-Mazcorro, S.L. Ishaq, M.V. Rodriguez-Herrera, C.A. Garcia-Hernandez, J.R. Kawas, T.G. Nagaraja. Review: Are there indigenous Saccharomyces in the digestive tract of livestock animal species? Implications for health, nutrition and productivity traits. Animal 2020; 14(1) doi: 10.1017/S1751731119001599
|
| 197 |
Barbara C Olendzki, Taryn D Silverstein, Gioia M Persuitte, Yunsheng Ma, Katherine R Baldwin, David Cave. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutrition Journal 2014; 13(1) doi: 10.1186/1475-2891-13-5
|
| 198 |
Vivian Tullio. Probiotic Yeasts: A Developing Reality?. Journal of Fungi 2024; 10(7) doi: 10.3390/jof10070489
|
| 199 |
Julia María Alatorre-Cruz, Ricardo Carreño-López, Vanesa Vargas-Plaza, Lizbeth Barrios-Cortés, Yair Olovaldo Santiago-Sáenz, Claudia Fabiola Martínez-de la Peña, Norma Angélica Santiesteban-López, Graciela Catalina Alatorre-Cruz. Association Between Dyspeptic Symptoms and Eating Habits in the Colombian Population. Nutrients 2026; 18(2) doi: 10.3390/nu18020308
|
| 200 |
Hongbo Fu, Jinrong Li, Xunhua Xu, Caihuai Xia, Yajuan Pan, Xi Lou. Effectiveness and Safety of Saccharomyces Boulardii for the Treatment of Acute Gastroenteritis in the Pediatric Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/6234858
|
| 201 |
Ida M. Smith, Jeffrey E. Christensen, Nils Arneborg, Lene Jespersen, Junji Yodoi. Yeast Modulation of Human Dendritic Cell Cytokine Secretion: An In Vitro Study. PLoS ONE 2014; 9(5) doi: 10.1371/journal.pone.0096595
|
| 202 |
Xiaoqiong Gu, Jean X.Y. Sim, Wei Lin Lee, Liang Cui, Yvonne F.Z. Chan, Ega Danu Chang, Yii Ean Teh, An-Ni Zhang, Federica Armas, Franciscus Chandra, Hongjie Chen, Shijie Zhao, Zhanyi Lee, Janelle R. Thompson, Eng Eong Ooi, Jenny G. Low, Eric J. Alm, Shirin Kalimuddin. Gut Ruminococcaceae levels at baseline correlate with risk of antibiotic-associated diarrhea. iScience 2022; 25(1) doi: 10.1016/j.isci.2021.103644
|
| 203 |
Rameesha Abid, Hassan Waseem, Jafar Ali, Shakira Ghazanfar, Ghulam Muhammad Ali, Abdelbaset Mohamed Elasbali, Salem Hussain Alharethi. Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. Journal of Fungi 2022; 8(5) doi: 10.3390/jof8050444
|
| 204 |
Abdulaziz Sulaiman Alsuwaylihi, Fiona McCullough. The safety and efficacy of probiotic supplementation for critically ill adult patients: a systematic review and meta-analysis. Nutrition Reviews 2023; 81(3) doi: 10.1093/nutrit/nuac059
|
| 205 |
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham, Charles E. Edmiston. Clostridium difficile. Journal of Parenteral and Enteral Nutrition 2012; 36(6) doi: 10.1177/0148607112446703
|
| 206 |
Beata Sulik-Tyszka, Emilian Snarski, Magda Niedźwiedzka, Małgorzata Augustyniak, Thorvald Nilsen Myhre, Anna Kacprzyk, Ewa Swoboda-Kopeć, Marta Roszkowska, Jadwiga Dwilewicz-Trojaczek, Wiesław Wiktor Jędrzejczak, Marta Wróblewska. Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients. Probiotics and Antimicrobial Proteins 2018; 10(2) doi: 10.1007/s12602-017-9332-4
|
| 207 |
Ener Cagri Dinleyici, Ates Kara, Metehan Ozen, Yvan Vandenplas. Saccharomyces boulardiiCNCM I-745 in different clinical conditions. Expert Opinion on Biological Therapy 2014; 14(11) doi: 10.1517/14712598.2014.937419
|
| 208 |
Zachary J. Waldrip, Lyle Burdine, Eric C. Peterson, Randall R. Rainwater, Yoobin Min, Marie Shluterman Burdine. A functional surface display system in Saccharomyces boulardii for protein absorption in simulated intestinal fluids. iScience 2025; 28(9) doi: 10.1016/j.isci.2025.113303
|
| 209 |
Lynne V. McFarland, Ramesh Srinivasan, Rajendra P. Setty, Sridhar Ganapathy, Ashish Bavdekar, Monjori Mitra, Bhaskar Raju, Neelam Mohan. Specific Probiotics for the Treatment of Pediatric Acute Gastroenteritis in India. JPGN Reports 2021; 2(3) doi: 10.1097/PG9.0000000000000079
|
| 210 |
Rebecka Ventin-Holmberg, Miikka Höyhtyä, Schahzad Saqib, Katri Korpela, Anne Nikkonen, Anne Salonen, Willem M. de Vos, Kaija-Leena Kolho. The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10548-7
|
| 211 |
Lynne Vernice McFarland, Metehan Ozen, Ener Cagri Dinleyici, Shan Goh. Comparison of pediatric and adult antibiotic-associated diarrhea and <i>Clostridium difficile</i> infections. World Journal of Gastroenterology 2016; 22(11): 3078-3104 doi: 10.3748/wjg.v22.i11.3078
|
| 212 |
Julian Andrés Mateus Rodríguez, Patricia Rodríguez Sanz, Edgar Kostandyan, Rubén Palacios Sanchez, María Luz Pino Roque, Patricia Chaves Vasquez, Pedro Roy Millán. Mitigating Diarrhoea-Related Inflammation in Frail Older Adults with Postbiotic-Enhanced Oral Rehydration Solution: Insights from a Randomised, Double-Blind, Placebo-Controlled Study. Geriatrics 2025; 10(2) doi: 10.3390/geriatrics10020034
|
| 213 |
Alexander Rapoport. Biotechnology of Yeasts and Filamentous Fungi. 2017; doi: 10.1007/978-3-319-58829-2_4
|
| 214 |
Thao D. Nguyen. Tailored management of chronic bacterial prostatitis with sequential fluoroquinolones and adverse effect mitigation strategies: A case report. IDCases 2025; 42 doi: 10.1016/j.idcr.2025.e02410
|
| 215 |
Sekyung Lee, Sang Min Kim, Hyung Joo Suh, Sung Hee Han, Yejin Ahn. Saccharomyces cerevisiae var. boulardii (HO12) Improves Loperamide-Induced Constipation in Rats via Modulation of Intestinal Neurotransmitters and SCFA Production. Journal of Microbiology and Biotechnology 2025; 35 doi: 10.4014/jmb.2508.08040
|
| 216 |
Alessandro Tonacci, Francesca Gorini. Sensory Characteristics of Probiotic-Containing Foods: A Multidisciplinary Perspective on Enhancing Acceptability and Consumer Adherence. Nutrients 2025; 18(1) doi: 10.3390/nu18010032
|
| 217 |
Ameet Patki, K Kunjimoideen, Sheetal Sawankar, Rajul Tyagi, Vandana Hegde, Jyoti Budi. Expert Opinion on the Use of Probiotics in Recurrent Pregnancy Loss. Cureus 2025; doi: 10.7759/cureus.81056
|
| 218 |
Eleni Alaverntian, Eugenia Papadaki. Probiotic Potential of Saccharomyces cerevisiae var. boulardii, Weizmannia coagulans and Lacticaseibacillus rhamnosus as Commercial Supplements: In Vitro Gastrointestinal Kinetics, Pharmaceutical Stability and Antioxidant Support in Chamomile Tea. Microbiology Research 2026; 17(4) doi: 10.3390/microbiolres17040082
|
| 219 |
Valeria Agamennone, Cyrille A. M. Krul, Ger Rijkers, Remco Kort. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0831-x
|
| 220 |
Junsang Hwang, Ina Bang, Donghyuk Kim, Seung Chul Shin, Young-Wook Chin, Tae-Wan Kim, Hyo Jin Kim. Genome sequence of the potential probiotic eukaryote Saccharomyces cerevisiae KCCM 51299. 3 Biotech 2020; 10(4) doi: 10.1007/s13205-020-02174-9
|
| 221 |
Ayodeji Awoyemi, Cristiane Mayerhofer, Alex S. Felix, Johannes R. Hov, Samuel D. Moscavitch, Knut Tore Lappegård, Anders Hovland, Sigrun Halvorsen, Bente Halvorsen, Ida Gregersen, Asbjørn Svardal, Rolf K. Berge, Simen H. Hansen, Alexandra Götz, Kristian Holm, Pål Aukrust, Sissel Åkra, Ingebjørg Seljeflot, Svein Solheim, Andrea Lorenzo, Lars Gullestad, Marius Trøseid, Kaspar Broch. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine 2021; 70 doi: 10.1016/j.ebiom.2021.103511
|
| 222 |
Philippe Veisseire, Muriel Bonnet, Taous Saraoui, Cyril Poupet, Olivier Camarès, Marylise Gachinat, Cécile Callon, Guy Febvre, Christophe Chassard, Stéphanie Bornes. Investigation into In Vitro and In Vivo Caenorhabditis elegans Models to Select Cheese Yeasts as Probiotic Candidates for their Preventive Effects against Salmonella Typhimurium. Microorganisms 2020; 8(6) doi: 10.3390/microorganisms8060922
|
| 223 |
Patricia Kaufman, K. Erin O’Meara, Jason Hawrelak. Preventing chemotherapy-induced diarrhea and microbiota imbalances with prebiotics and probiotics in breast cancer treatment: A case report. Gut Microbes Reports 2024; 1(1) doi: 10.1080/29933935.2024.2379475
|
| 224 |
Vanita Mulay, Dhanashri Satav, Austin Fernandes, Priyanka Pisalwar, Shadab Ahmed. Recent Trends and The Future of Antimicrobial Agents - Part I. 2023; doi: 10.2174/9789815079609123010008
|
| 225 |
Lee E. Morrow, Vijaya Gogineni, Mark A. Malesker. Probiotic, prebiotic, and synbiotic use in critically ill patients. Current Opinion in Critical Care 2012; 18(2) doi: 10.1097/MCC.0b013e3283514b17
|
| 226 |
Mariana Buranelo Egea, Josemar Gonçalves de Oliveira Filho, Ailton Cesar Lemes. Investigating the Efficacy of Saccharomyces boulardii in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far. International Journal of Molecular Sciences 2023; 24(15) doi: 10.3390/ijms241512015
|
| 227 |
Lidia Ibáñez, Rodolphe Pontier-Bres, Frederic Larbret, Akila Rekima, Valérie Verhasselt, Claudine Blin-Wakkach, Dorota Czerucka. Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium Infection. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00643
|
| 228 |
Igor V. Maev, Dmitry N. Andreev, Philipp S. Sokolov, Aleksei К. Fomenko, Mikhail K. Devkota, Nikolai G. Andreev, Andrew V. Zaborovsky. Efficacy of <i>Saccharomyces boulardii</i> CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19. Terapevticheskii arkhiv 2022; 94(10) doi: 10.26442/00403660.2022.10.201881
|
| 229 |
Jean L. Schoeni. Compendium of Methods for the Microbiological Examination of Foods. 2015; doi: 10.2105/MBEF.0222.025
|
| 230 |
Kiyana Tafazzoli, Mehrdad Ghavami, Kianoush Khosravi-Darani. Investigation of impact of siderophore and process variables on production of iron enriched Saccharomyces boulardii by Plackett–Burman design. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70467-7
|
| 231 |
Yumeng Dong, Tiangang Xu, Guozheng Xiao, Ziyan Hu, Jingyu Chen. Opportunities and challenges for synthetic biology in the therapy of inflammatory bowel disease. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.909591
|
| 232 |
Lynne V McFarland. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 2014; 4(8) doi: 10.1136/bmjopen-2014-005047
|
| 233 |
Sandeep Jaiswal, Tarun Pant, Mangesh Suryavanshi, Usha Antony. Microbiological diversity of fermented food Bhaati Jaanr and its antioxidant and anti-inflammatory properties: Effect against colon cancer. Food Bioscience 2023; 55 doi: 10.1016/j.fbio.2023.102822
|
| 234 |
Monique Michels, Emily Córneo, Luana Cucker, Carla Sasso Simon, Gabriel Fernandes Alves de Jesus, Carolina Michels, Kristian Madeira, Ana Paula Voytena, Marina Rossetto, Fernanda Ramlov, Danusa de Castro Damásio, Felipe Dal-Pizzol. Bifidobacterium lactis CCT 7858 Improves Gastrointestinal Symptoms by Antibiotics Treatment: a Double-Blind, Randomized, Placebo-Controlled Trial. Probiotics and Antimicrobial Proteins 2023; 15(3) doi: 10.1007/s12602-021-09900-6
|
| 235 |
Xiali Qin, Qing Zhao, Qianjing Zhao, Lijiao Yang, Wanyu Li, Jingyi Wu, Tianyu Liu, Weilong Zhong, Kui Jiang, Wentian Liu, Bangmao Wang, Sinan Wang, Hailong Cao. A Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor. Pharmacological Research 2024; 208 doi: 10.1016/j.phrs.2024.107372
|
| 236 |
Saleem Ahmad, Muhammad Usman, Maryam Bibi, Muhammad Nauman Aftab, Muhammad Shahbaz Aslam. Small but mighty: the human mycobiome as an immunopharmacological regulator of inflammation and autoimmunity. International Immunopharmacology 2026; 185 doi: 10.1016/j.intimp.2026.116968
|
| 237 |
Fernanda Silva Farinazzo, Eduardo Silva Farinazzo, Wilma Aparecida Spinosa, Sandra Garcia. Saccharomyces boulardii: Optimization of simultaneous saccharification and fermentation of cell production in organic and conventional apple substrate pulp. Food Science and Biotechnology 2017; 26(4) doi: 10.1007/s10068-017-0123-1
|
| 238 |
|
| 239 |
Patrick Alexander Wachholz, Paulo José Fortes Villas Boas, Vânia dos Santos Nunes. Probiotics, Prebiotics, and Synbiotics. 2016; doi: 10.1016/B978-0-12-802189-7.00050-2
|
| 240 |
Vanessa Liévin-Le Moal. A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB. Therapeutic Advances in Gastroenterology 2016; 9(1) doi: 10.1177/1756283X15602831
|
| 241 |
João Inácio, Heide-Marie Daniel. Yeasts in Natural Ecosystems: Ecology. 2017; doi: 10.1007/978-3-319-61575-2_8
|
| 242 |
Abdul Arif Khan, Mohsin Khurshid, Shahanavaj Khan, Aws Alshamsan. Gut Microbiota and Probiotics: Current Status and Their Role in Cancer Therapeutics. Drug Development Research 2013; 74(6) doi: 10.1002/ddr.21087
|
| 243 |
Lindsay M. Urben, Jennifer Wiedmar, Erica Boettcher, Rodrigo Cavallazzi, Robert G. Martindale, Stephen A. McClave. Bugs or Drugs: Are Probiotics Safe for Use in the Critically Ill?. Current Gastroenterology Reports 2014; 16(7) doi: 10.1007/s11894-014-0388-y
|
| 244 |
Vincent Cascio, Daniel Gittings, Kristen Merloni, Matthew Hurton, David Laprade, Nicanor Austriaco. S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii,from acid-induced cell death. BMC Microbiology 2013; 13(1) doi: 10.1186/1471-2180-13-35
|
| 245 |
Evie H. Carchman, Andrew B. Peitzman, Richard L. Simmons, Brian S. Zuckerbraun. The role of acute care surgery in the treatment of severe, complicated Clostridium difficile–associated disease. Journal of Trauma and Acute Care Surgery 2012; 73(4) doi: 10.1097/TA.0b013e318265d19f
|
| 246 |
Sonia S. Yoon, Jun Sun. Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways. Gastroenterology Research and Practice 2011; 2011 doi: 10.1155/2011/971938
|
| 247 |
Dongming Zhang, Amin Yousefvand, Matti Wahlsten, Per E.J. Saris. Postbiotic bread with neurotransmitter γ-aminobutyric acid (GABA) by supplementation with Lactiplantibacillus plantarum H64 fermentate of spent probiotic brewer's yeast Saccharomyces boulardii. Food Bioscience 2025; 68 doi: 10.1016/j.fbio.2025.106766
|
| 248 |
Remo Poto, Gianluca laniro, Amato de Paulis, Giuseppe Spadaro, Gianni Marone, Antonio Gasbarrini, Gilda Varricchi. Is there a role for microbiome-based approach in common variable immunodeficiency?. Clinical and Experimental Medicine 2023; 23(6) doi: 10.1007/s10238-023-01006-3
|
| 249 |
Ana Belén Díaz, Enrique Durán-Guerrero, Sergio Valiente, Remedios Castro, Cristina Lasanta. Development and Characterization of Probiotic Beers with Saccharomyces boulardii as an Alternative to Conventional Brewer’s Yeast. Foods 2023; 12(15) doi: 10.3390/foods12152912
|
| 250 |
Kamila Goderska, Peace Oluwamuyiwa Obey. Characteristics of synbiotics and lactobionic acid. Journal of Functional Foods 2025; 134 doi: 10.1016/j.jff.2025.107058
|
| 251 |
Natalia Ekstedt, Dominika Jamioł-Milc, Joanna Pieczyńska. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease. Nutrients 2024; 16(13) doi: 10.3390/nu16132092
|
| 252 |
Massimo Iorizzo, Francesca Coppola, Francesco Letizia, Bruno Testa, Elena Sorrentino. Role of Yeasts in the Brewing Process: Tradition and Innovation. Processes 2021; 9(5) doi: 10.3390/pr9050839
|
| 253 |
Samantha E. Bautista Marín, Teresita de Jesus Hijuitl Valeriano, Gerardo Mariscal Landín, José Guadalupe Gómez Soto, Christian I. Narváez Briones, Konisgmar Escobar García, Tércia Cesária Reis de Souza. Asociación entre el destete, la salud intestinal de lechones destetados y el consumo de dietas con probióticos y concentrado de proteína de papa. Archivos Latinoamericanos de Producción Animal 2023; 31(2) doi: 10.53588/alpa.310201
|
| 254 |
Karl Alex Hedin, Mohammad H Mirhakkak, Troels Holger Vaaben, Carmen Sands, Mikael Pedersen, Adam Baker, Ruben Vazquez-Uribe, Sascha Schäuble, Gianni Panagiotou, Anja Wellejus, Morten Otto Alexander Sommer.
Saccharomyces boulardii enhances anti-inflammatory effectors and AhR activation via metabolic interactions in probiotic communities. The ISME Journal 2024; 18(1) doi: 10.1093/ismejo/wrae212
|
| 255 |
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterología. Revista de Gastroenterología de México 2017; 82(2) doi: 10.1016/j.rgmx.2016.08.004
|
| 256 |
M. V. Alagova, I. G. Samoylova, K. D. Ermolenko, A. K. Ratnikova. Comparative efficacy of multi-strain and single-strain probiotics in the comprehensive treatment of rotavirus infections in children. Meditsinskiy sovet = Medical Council 2026; 20(5) doi: 10.21518/ms2026-159
|
| 257 |
Monika E. Jach, Anna Serefko. Diet, Microbiome and Health. 2018; doi: 10.1016/B978-0-12-811440-7.00009-0
|
| 258 |
Pengya Feng, Ze Ye, Apurva Kakade, Amanpreet Kaur Virk, Xiangkai Li, Pu Liu. A Review on Gut Remediation of Selected Environmental Contaminants: Possible Roles of Probiotics and Gut Microbiota. Nutrients 2018; 11(1) doi: 10.3390/nu11010022
|
| 259 |
Herbert L. DuPont. Diagnosis and Management of Clostridium difficile Infection. Clinical Gastroenterology and Hepatology 2013; 11(10) doi: 10.1016/j.cgh.2013.03.016
|
| 260 |
Cristiane C.K. Mayerhofer, Ayodeji Awoyemi, Johannes R. Hov, Marius Trøseid, Kaspar Broch. Reply: Potential Risk Associated with Direct Modulation of the Gut Flora in Patients with Heart Failure. ESC Heart Failure 2019; 6(3) doi: 10.1002/ehf2.12437
|
| 261 |
S. A. Ryabtsevа, A. G. Khramtsov, S. N. Sazanova, R. O. Budkevich, N. M. Fedortsov, A. A. Veziryan. Probiotic Properties of Saccharomycetes (Review). Прикладная биохимия и микробиология 2023; 59(2) doi: 10.31857/S0555109923010087
|
| 262 |
Hassan Barakat, Sally S. Sakr, Hani A. Alfheeaid, Khalid A. Alsaleem, Raghad M. Alhomaid, Tamer M. El-Messery, Tarek A. Ebeid, Essam Y. Abdul-Hafeez. Oxidative Stress–Gut Microbiome Crosstalk: Intestinal Redox Imbalance and Probiotics Therapeutic Potential. Antioxidants 2026; 15(5) doi: 10.3390/antiox15050533
|
| 263 |
Manning Li, Ying Xie. Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1441185
|
| 264 |
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan, Voon Chen Yong. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01136
|
| 265 |
|
| 266 |
Benjamin Offei, Paul Vandecruys, Stijn De Graeve, María R. Foulquié-Moreno, Johan M. Thevelein. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii. Genome Research 2019; 29(9) doi: 10.1101/gr.243147.118
|
| 267 |
Veilumuthu Pattapulavar, Sathiyabama Ramanujam, Bhagyashree Kini, John Godwin Christopher. Probiotic-derived postbiotics: a perspective on next-generation therapeutics. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1624539
|
| 268 |
A. Poncelet, L. Ruelle, D. Konopnicki, V.Y. Miendje Deyi, N. Dauby. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration. Infectious Diseases Now 2021; 51(3) doi: 10.1016/j.idnow.2020.12.003
|
| 269 |
Carlotta Suardi, Emanuela Cazzaniga, Stephanie Graci, Dario Dongo, Paola Palestini. Link between Viral Infections, Immune System, Inflammation and Diet. International Journal of Environmental Research and Public Health 2021; 18(5) doi: 10.3390/ijerph18052455
|
| 270 |
Anggeta Bella Siez Kanita, Yoga Dwi Jatmiko. Screening and Identification of Potential Indigenous Yeasts Isolated During Fermentation of Wine Coffee. Malaysian Applied Biology 2023; 52(3) doi: 10.55230/mabjournal.v52i3.2562
|
| 271 |
Mohammad Abdollahi, Amir Hossein Abdolghaffari, Maziar Gooshe, Farnaz Ghasemi-Niri. Probiotics, Prebiotics, and Synbiotics. 2016; doi: 10.1016/B978-0-12-802189-7.00015-0
|
| 272 |
Taned Chitapanarux, Umaporn Wiracha, Poramed Winichakoon, Parichat Salee, Patrinee Traisathit. Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-04986-2
|
| 273 |
Carolina Hernández-Haro, Silvia Llopis, María Molina, Lucía Monteoliva, Concha Gil. Immunoproteomic profiling of Saccharomyces cerevisiae systemic infection in a murine model. Journal of Proteomics 2015; 112 doi: 10.1016/j.jprot.2014.08.008
|
| 274 |
Xiang Gao, Jingwen Liu, Li Li, Wei Liu, Meiyan Sun. A Brief Review of Nutraceutical Ingredients in Gastrointestinal Disorders: Evidence and Suggestions. International Journal of Molecular Sciences 2020; 21(5) doi: 10.3390/ijms21051822
|
| 275 |
Longteng Ma, Lifen Wang, Zixi Zhang, Dingfu Xiao. Research Progress of Biological Feed in Beef Cattle. Animals 2023; 13(16) doi: 10.3390/ani13162662
|
| 276 |
Linda Gouka, Cristina Serra i Melendez, Nelli Vardazaryan, Knud Nor Nielsen, Leise Riber, Lars Hestbjerg Hansen, Jos M. Raaijmakers, Michael F. Seidl, Chrats Melkonian, Viviane Cordovez. Genomic insights into adaptative traits of phyllosphere yeasts. Environmental Microbiome 2026; 21(1) doi: 10.1186/s40793-025-00839-7
|
| 277 |
Rodolphe Pontier-Bres, Patrick Rampal, Jean-François Peyron, Patrick Munro, Emmanuel Lemichez, Dorota Czerucka. The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin. Toxins 2015; 7(11) doi: 10.3390/toxins7114455
|
| 278 |
Toufic A. Kabbani, Kumar Pallav, Scot E. Dowd, Javier Villafuerte-Galvez, Rohini R. Vanga, Natalia E. Castillo, Joshua Hansen, Melinda Dennis, Daniel A. Leffler, Ciarán P. Kelly. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes 2017; 8(1) doi: 10.1080/19490976.2016.1267890
|
| 279 |
Maria Assunta Zocco, Matteo Garcovich, Antonio Gasbarrini. Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use. American Journal of Gastroenterology 2012; 107(9) doi: 10.1038/ajg.2012.222
|
| 280 |
Elma Hrustemović. The interaction between the gut microbiota, nutrition, and human health. Journal of the Science of Food and Agriculture 2026; 106(9) doi: 10.1002/jsfa.70395
|
| 281 |
Jean-Marie Vetel, Habib Hamza, Benoît Coffin, Philippe Lehert. Racecadotril Efficacy in the Symptomatic Treatment of Adult Acute Diarrhoea: A Systematic Review and Meta-Analysis. International Journal of Clinical Medicine 2014; 5(07) doi: 10.4236/ijcm.2014.57052
|
| 282 |
Kabolobari Barielnu Bornu, Ulusoy Beyza, Kaya Yıldırım Fatma, Kaynarca Doruk, Marcus Victor. Resistance of Saccharomyces boulardii to technological process, and its in-vitro probiotic properties. International Food Research Journal 2024; 31(6) doi: 10.47836/ifrj.31.6.11
|
| 283 |
Kate L. Pumpa, Andrew J. McKune, Joanna Harnett. A novel role of probiotics in improving host defence of elite rugby union athlete: A double blind randomised controlled trial. Journal of Science and Medicine in Sport 2019; 22(8) doi: 10.1016/j.jsams.2019.03.013
|
| 284 |
Mary Hickson. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therapeutic Advances in Gastroenterology 2011; 4(3) doi: 10.1177/1756283X11399115
|
| 285 |
Mehdi Goudarzi, Sima Sadat Seyedjavadi, Hossein Goudarzi, Elnaz Mehdizadeh Aghdam, Saeed Nazeri. Clostridium difficileInfection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica 2014; 2014 doi: 10.1155/2014/916826
|
| 286 |
Glenn R. Gibson, Robert J. Brummer, Erika Isolauri, Herbert Lochs, Lorenzo Morelli, Theo Ockhuizen, Ian R. Rowland, Jürgen Schrezenmeir, Catherine Stanton, Kristin Verbeke. The design of probiotic studies to substantiate health claims.. Gut Microbes 2011; 2(5) doi: 10.4161/gmic.2.5.18002
|
| 287 |
Tyler Culpepper, Krithika Senthil, Jessica Vlcek, Anthony Hazelton, Mairead K. Heavey, Rani S. Sellers, Juliane Nguyen, Janelle C. Arthur. Engineered Probiotic Saccharomyces boulardii Reduces Colitis-Associated Colorectal Cancer Burden in Mice. Digestive Diseases and Sciences 2025; 70(7) doi: 10.1007/s10620-025-09008-9
|
| 288 |
Ghasem Bagherpour, Hosnie Ghasemi, Bahare Zand, Najmeh Zarei, Farzin Roohvand, Esmat M. Ardakani, Mohammad Azizi, Vahid Khalaj. Oral Administration of Recombinant Saccharomyces boulardii Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in Mice. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00723
|
| 289 |
Laura Canonico, Emanuele Zannini, Maurizio Ciani, Francesca Comitini. Assessment of non-conventional yeasts with potential probiotic for protein-fortified craft beer production. LWT 2021; 145 doi: 10.1016/j.lwt.2021.111361
|
| 290 |
Christine S. Cocanour. Best Strategies in Recurrent or PersistentClostridium difficileInfection. Surgical Infections 2011; 12(3) doi: 10.1089/sur.2010.080
|
| 291 |
Ben‐Gang Zhou, Ling‐Xiao Chen, Bo Li, Lin‐Yan Wan, Yao‐Wei Ai. Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis. Helicobacter 2019; 24(5) doi: 10.1111/hel.12651
|
| 292 |
Silvia Cristina Vergara, María José Leiva, María Victoria Mestre, Fabio Vazquez, María Cristina Nally, Yolanda Paola Maturano. Non-saccharomyces yeast probiotics: revealing relevance and potential. FEMS Yeast Research 2023; 23 doi: 10.1093/femsyr/foad041
|
| 293 |
Geetika M. Ahlawat, Prabhat K. Singh. Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review. Current Therapeutic Research 2023; 99 doi: 10.1016/j.curtheres.2023.100721
|
| 294 |
Ricardo Donizete Teixeira, Handray Fernandes de Souza, Fabiano Vaquero Silva Junior, Felipe Donizete Teixeira, Karina Nascimento Pereira, Amanda Cristina Dias de Oliveira, Adriano Gomes da Cruz, Igor Viana Brandi, Giovana Fumes Ghantous, Eliana Setsuko Kamimura. Shelf Life and Sensory Evaluation of a Potentially Probiotic Mead Produced by the Mixed Fermentation of Saccharomyces boulardii and Kombucha. Beverages 2025; 11(6) doi: 10.3390/beverages11060166
|
| 295 |
Lei Yu, Xue-ke Zhao, Ming-liang Cheng, Guo-zhen Yang, Bi Wang, Hua-juan Liu, Ya-xin Hu, Li-li Zhu, Shuai Zhang, Zi-wen Xiao, Yong-mei Liu, Bao-fang Zhang, Mao Mu.
Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01271-9
|
| 296 |
Jing Yu, Yi-Ming Lv, Peng Yang, Yi-Zhou Jiang, Xiang-Rong Qin, Xiao-Yong Wang. Safety and effectiveness of vonoprazan-based rescue therapy for <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2023; 29(20): 3133-3144 doi: 10.3748/wjg.v29.i20.3133
|
| 297 |
Patrice D Cani, Matthias Van Hul. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Current Opinion in Biotechnology 2015; 32 doi: 10.1016/j.copbio.2014.10.006
|
| 298 |
Kamila Sabino Batista, Juliana Gondim de Albuquerque, Maria Helena Araújo de Vasconcelos, Maria Luiza Rolim Bezerra, Mariany Bernardino da Silva Barbalho, Rafael Oliveira Pinheiro, Jailane de Souza Aquino. Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?. Nutrition Research Reviews 2023; 36(2) doi: 10.1017/S0954422421000317
|
| 299 |
Kanyarat Kanyakam, Cheunjit Prakitchaiwattana. Influence of Isolation Source on the Probiotic Properties and Health Benefits of Yeasts: Insights from Metabarcoding and Cultivation Approaches. Applied Microbiology 2025; 5(3) doi: 10.3390/applmicrobiol5030076
|
| 300 |
Heike Stier, Stephan C. Bischoff. Saccharomyces boulardii CNCM I-745 beeinflusst das darmassoziierte Immunsystem. MMW - Fortschritte der Medizin 2017; 159(S5) doi: 10.1007/s15006-017-9802-3
|
| 301 |
Jean-Charles Delchier, Fernand Vicari. Hp à l’UEGW d’Amsterdam 2012. Hegel 2012; (4) doi: 10.3917/heg.024.0104
|
| 302 |
Annick Lejeune, Philippe Thonart, Frank Delvigne. Stress microbien lors du processus d’extrapolation: Approche physique et biologique. Cerevisia 2013; 38(3) doi: 10.1016/j.cervis.2013.10.002
|
| 303 |
Subhasree Mal, Tridip K. Das, Shrabani Pradhan, Kuntal Ghosh. Probiotics as a Therapeutic Approach for Non-infectious Gastric Ulcer Management: a Comprehensive Review. Probiotics and Antimicrobial Proteins 2025; 17(1) doi: 10.1007/s12602-024-10348-7
|
| 304 |
Yehuda Ringel, Eamonn MM Quigley, Henry C Lin. Using Probiotics in Gastrointestinal Disorders. The American Journal of Gastroenterology Supplements 2012; 1(1) doi: 10.1038/ajgsup.2012.7
|
| 305 |
Constantinos Karaolis, George Botsaris, Iakovos Pantelides, Dimitris Tsaltas. Potential application of Saccharomyces boulardii as a probiotic in goat's yoghurt: survival and organoleptic effects. International Journal of Food Science & Technology 2013; 48(7) doi: 10.1111/ijfs.12111
|
| 306 |
Swastik Sen, Thomas J. Mansell. Yeasts as probiotics: Mechanisms, outcomes, and future potential. Fungal Genetics and Biology 2020; 137 doi: 10.1016/j.fgb.2020.103333
|
| 307 |
Muhan LÜ, Shan Yu, Jiaqi Deng, Qiong Yan, Chun Yang, Guodong Xia, Xian Zhou, Anna Roujeinikova. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials. PLOS ONE 2016; 11(10) doi: 10.1371/journal.pone.0163743
|
| 308 |
Sarath Gopalan , Sridhar Ganapathy, Monjori Mitra, Neha ., Devesh Kumar Joshi, Krishna C Veligandla, Rahul Rathod, Bhavesh P Kotak. Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review. Cureus 2023; doi: 10.7759/cureus.46314
|
| 309 |
Annika Reintam Blaser, Adam M. Deane, Sonja Fruhwald. Diarrhoea in the critically ill. Current Opinion in Critical Care 2015; 21(2) doi: 10.1097/MCC.0000000000000188
|
| 310 |
Qicheng Lu, Junli Niu, Yanyan Wu, Wenju Zhang. Effects of Saccharomyces cerevisiae var. boulardii on growth, incidence of diarrhea, serum immunoglobulins, and rectal microbiota of suckling dairy calves. Livestock Science 2022; 258 doi: 10.1016/j.livsci.2022.104875
|
| 311 |
Olga Sjomina, Inese Poļaka, Jekaterina Suhorukova, Reinis Vangravs, Sergejs Paršutins, Viktoria Knaze, Jin Young Park, Rolando Herrero, Raul Murillo, Mārcis Leja. Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation. European Journal of Cancer Prevention 2024; 33(3) doi: 10.1097/CEJ.0000000000000858
|
| 312 |
Pedro Pais, Vanda Almeida, Melike Yılmaz, Miguel C. Teixeira. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?. Journal of Fungi 2020; 6(2) doi: 10.3390/jof6020078
|
| 313 |
Kelly R. Kan, Marco Constante, Sara Rahmani, Gaston H. Rueda, Mark Wulczynski, Maria Ines Pinto-Sanchez, Xavier Roux, Premysl Bercik, Heather J. Galipeau, Alberto Caminero, Elena F. Verdu.
Saccharomyces boulardii
CNCM I-745 synergizes with the small intestinal microbiota to boost AhR signaling in celiac disease
. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2664640
|
| 314 |
Jürgen Stein, Axel Dignaß. Prävention und Therapie von entzündlichen Magen‐/Darm‐Erkrankungen. Pharmazie in unserer Zeit 2012; 41(2) doi: 10.1002/pauz.201100460
|
| 315 |
Judit Villar-García, Robert Güerri-Fernández, Andrés Moya, Alicia González, Juan J. Hernández, Elisabet Lerma, Ana Guelar, Luisa Sorli, Juan P. Horcajada, Alejandro Artacho, Giuseppe D´Auria, Hernando Knobel, Alan Landay. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. PLOS ONE 2017; 12(4) doi: 10.1371/journal.pone.0173802
|
| 316 |
Hania Szajewska, Maciej Kołodziej, Bartłomiej M. Zalewski. Systematic review with meta‐analysis: Saccharomyces boulardii for treating acute gastroenteritis in children—a 2020 update. Alimentary Pharmacology & Therapeutics 2020; 51(7) doi: 10.1111/apt.15659
|
| 317 |
Daniel J. Selig, Jesse P. DeLuca, Qigui Li, Hsiuling Lin, Ken Nguyen, Shaylyn M. Scott, Jason C. Sousa, Chau T. Vuong, Lisa H. Xie, Jeffrey R. Livezey. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin. Drug Metabolism and Personalized Therapy 2020; 0(0) doi: 10.1515/dmpt-2019-0032
|
| 318 |
Fereshteh Ansari, Shohre Alian Samakkhah, Ali Bahadori, Seyedeh Maedeh Jafari, Mojtaba Ziaee, Mohammad Taghi Khodayari, Hadi Pourjafar. Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Critical Reviews in Food Science and Nutrition 2023; 63(4) doi: 10.1080/10408398.2021.1949577
|
| 319 |
J. Buttar, E. Kon, A. Lee, G. Kaur, G. Lunken. Effect of diet on the gut mycobiome and potential implications in inflammatory bowel disease. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2399360
|
| 320 |
M Rauch, SV Lynch. The potential for probiotic manipulation of the gastrointestinal microbiome. Current Opinion in Biotechnology 2012; 23(2) doi: 10.1016/j.copbio.2011.11.004
|
| 321 |
Chao-Hung Kuo, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Sophie S. W. Wang, Yen-Hsu Chen, Ming-Chia Hsieh, Ming-Feng Hou, Deng-Chyang Wu. The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012. Gastroenterology Research and Practice 2012; 2012 doi: 10.1155/2012/168361
|
| 322 |
|
| 323 |
Kimia Motlagh Asghari, Neda Dolatkhah, Hormoz Ayromlou, Fatemeh Mirnasiri, Taher Dadfar, Maryam Hashemian. The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46047-6
|
| 324 |
Carlo Airola, Andrea Severino, Serena Porcari, William Fusco, Benjamin H. Mullish, Antonio Gasbarrini, Giovanni Cammarota, Francesca Romana Ponziani, Gianluca Ianiro. Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy. Antibiotics 2023; 12(5) doi: 10.3390/antibiotics12050868
|
| 325 |
Nitin Verma, Jatin Kumar, Neha Kanojia, Komal Thapa, Kamal Dua. Advanced Drug Delivery Systems for Colonic Disorders. 2024; doi: 10.1016/B978-0-443-14044-0.00011-9
|
| 326 |
|
| 327 |
Marco Constante, Giada De Palma, Jun Lu, Jennifer Jury, Liam Rondeau, Alberto Caminero, Stephen M. Collins, Elena F. Verdu, Premysl Bercik. Saccharomyces boulardii CNCM I‐745 modulates the microbiota–gut–brain axis in a humanized mouse model of Irritable Bowel Syndrome. Neurogastroenterology & Motility 2021; 33(3) doi: 10.1111/nmo.13985
|
| 328 |
|
| 329 |
Z.X. He, B. Ferlisi, E. Eckert, H.E. Brown, A. Aguilar, M.A. Steele. Supplementing a yeast probiotic to pre-weaning Holstein calves: Feed intake, growth and fecal biomarkers of gut health. Animal Feed Science and Technology 2017; 226 doi: 10.1016/j.anifeedsci.2017.02.010
|
| 330 |
Selina Mawunyo Ayivi-Tosuh, Aboagye Kwarteng Dofuor, Jennifer Afua Afrifa Yamoah, Blessing Kwabena Gayi, Albert Fynn Aiduenu, Angelina Akomea, Susanna Awinsongya Anovunga, William Ekloh, Laud Anthony Basing. Gut-Microbiome Interactions: Characterization, Therapeutic Implications and Machine Learning. Sage Open Pathology 2026; 19 doi: 10.1177/30502098251415109
|
| 331 |
|
| 332 |
Wenxin Wang, Sha Lu, Yuanqing Fu, Yuyun Yao, Wensheng Hu. Intestinal fungal dysbiosis in gestational diabetes mellitus is associated with adverse pregnancy outcomes. BMC Pregnancy and Childbirth 2026; 26(1) doi: 10.1186/s12884-026-08677-2
|
| 333 |
Karl Alex Hedin, Vanessa Emily Rees, Hongbin Zhang, Vibeke Kruse, Ruben Vazquez-Uribe, Morten Otto Alexander Sommer. Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-12806-0
|
| 334 |
Nathalie Ballet, Sarah Renaud, Hugo Roume, Fanny George, Pascal Vandekerckove, Mickaël Boyer, Mickaël Durand-Dubief. Saccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development Goals. Encyclopedia 2023; 3(2) doi: 10.3390/encyclopedia3020043
|
| 335 |
Gustavo Almeida Bastos, Elinalva Maciel Paulo, Ana Cristina Nascimento Chiaradia. Aceitabilidade de barra de cereais potencialmente probiótica. Brazilian Journal of Food Technology 2014; 17(2) doi: 10.1590/bjft.2014.012
|
| 336 |
Jeremy Cottrell, Kerstin Koenig, Roland Perfekt, Robert Hofmann. Comparison of Two Forms of Loperamide–Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical Trial. Drugs in R&D 2015; 15(4) doi: 10.1007/s40268-015-0111-y
|
| 337 |
Jingwen Liu, Haixia Ren, Fangting Yuan, Ming Shao, Hesheng Luo. The effects of Saccharomyces boulardii on rat colonic hypermotility induced by repeated water avoidance stress and the potential mechanism. PeerJ 2022; 10 doi: 10.7717/peerj.14390
|
| 338 |
Christina M Surawicz, Lawrence J Brandt, David G Binion, Ashwin N Ananthakrishnan, Scott R Curry, Peter H Gilligan, Lynne V McFarland, Mark Mellow, Brian S Zuckerbraun. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. American Journal of Gastroenterology 2013; 108(4) doi: 10.1038/ajg.2013.4
|
| 339 |
Vivian Tullio. Yeast Genomics and Its Applications in Biotechnological Processes: What Is Our Present and Near Future?. Journal of Fungi 2022; 8(7) doi: 10.3390/jof8070752
|
| 340 |
Jennifer Joan Ryan, Douglas Allen Hanes, Morgan Beth Schafer, Jeremy Mikolai, Heather Zwickey. Effect of the ProbioticSaccharomyces boulardiion Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot Study. The Journal of Alternative and Complementary Medicine 2015; 21(5) doi: 10.1089/acm.2014.0063
|
| 341 |
Elena Hadjimbei, George Botsaris, Vlasios Goulas, Eleni Alexandri, Vassilis Gekas, Ioannis P Gerothanassis. Functional stability of goats' milk yoghurt supplemented with Pistacia atlantica resin extracts and Saccharomyces boulardii. International Journal of Dairy Technology 2020; 73(1) doi: 10.1111/1471-0307.12629
|
| 342 |
Michał Seweryn Karbownik, Joanna Kręczyńska, Anna Wiktorowska-Owczarek, Paulina Kwarta, Magdalena Cybula, Nebojša Stilinović, Tadeusz Pietras, Edward Kowalczyk. Decrease in Salivary Serotonin in Response to Probiotic Supplementation With Saccharomyces boulardii in Healthy Volunteers Under Psychological Stress: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.800023
|
| 343 |
Nuntra Suwantarat, David A. Bobak. Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection. Current Infectious Disease Reports 2011; 13(1) doi: 10.1007/s11908-010-0155-7
|
| 344 |
Joshua Z Goldenberg, Stephanie SY Ma, Jane D Saxton, Mark R Martzen, Per O Vandvik, Kristian Thorlund, Gordon H Guyatt, Bradley C Johnston. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD006095.pub3
|
| 345 |
C.Q. Tan, H.K. Wei, H.Q. Sun, G. Long, J.T. Ao, S.W. Jiang, J. Peng. Effects of supplementing sow diets during two gestations with konjac flour and Saccharomyces boulardii on constipation in peripartal period, lactation feed intake and piglet performance. Animal Feed Science and Technology 2015; 210 doi: 10.1016/j.anifeedsci.2015.10.013
|
| 346 |
Serhan Sakarya, Necati Gunay. Saccharomyces boulardii expresses neuraminidase activity selective for α2,3‐linked sialic acid that decreases Helicobacter pylori adhesion to host cells. APMIS 2014; 122(10) doi: 10.1111/apm.12237
|
| 347 |
Jungyeon Kim, Yu Eun Cheong, Sora Yu, Yong-Su Jin, Kyoung Heon Kim. Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component. Microbial Cell Factories 2022; 21(1) doi: 10.1186/s12934-022-01926-x
|
| 348 |
Maxime Poirier, Cindy Hugot, Madeleine Spatz, Gregory Da Costa, Alexia Lapiere, Chloé Michaudel, Camille Danne, Valérie Martin, Philippe Langella, Marie-Laure Michel, Harry Sokol, Patrick Boyaval, Mathias L. Richard. Effects of Five Filamentous Fungi Used in Food Processes on In Vitro and In Vivo Gut Inflammation. Journal of Fungi 2022; 8(9) doi: 10.3390/jof8090893
|
| 349 |
Angela Capece, Rossana Romaniello, Angela Pietrafesa, Gabriella Siesto, Rocchina Pietrafesa, Marianna Zambuto, Patrizia Romano. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added. International Journal of Food Microbiology 2018; 284 doi: 10.1016/j.ijfoodmicro.2018.06.028
|
| 350 |
C. Villot, T. Ma, D.L. Renaud, M.H. Ghaffari, D.J. Gibson, A. Skidmore, E. Chevaux, L.L. Guan, M.A. Steele. Saccharomyces cerevisiae boulardii CNCM I-1079 affects health, growth, and fecal microbiota in milk-fed veal calves. Journal of Dairy Science 2019; 102(8) doi: 10.3168/jds.2018-16149
|
| 351 |
Monika Elżbieta Jach, Ewa Sajnaga, Ewa Kozak, Anna Malm. Use of yeasts for prevention and therapy. Current Issues of Pharmacy and Medical Sciences 2013; 26(2) doi: 10.12923/j.2084-980X/26.2/a.17
|
| 352 |
Lynne V. McFarland, Shan Goh. Are probiotics and prebiotics effective in the prevention of travellers’ diarrhea: A systematic review and meta-analysis. Travel Medicine and Infectious Disease 2019; 27 doi: 10.1016/j.tmaid.2018.09.007
|
| 353 |
Michelle Gorbonosov, Lawrence Markel. A Clinician’s Evidence-Based Guide to Supplements. 2024; doi: 10.1007/978-3-031-66885-2_5
|
| 354 |
|
| 355 |
Dhiraj Prakash Dhotre, Bhagyashree Karmarkar. Metagenomics. 2025; doi: 10.1016/B978-0-323-91631-8.00011-1
|
| 356 |
Anders P. Jensen, Charlotte R. Bjørnvad. Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review. Journal of Veterinary Internal Medicine 2019; 33(5) doi: 10.1111/jvim.15554
|
| 357 |
Ibrahim Farhani, Ahad Yamchi, Hadi Razavi Nikoo, Fatemeh T. Shamsabadi, Shahriyar Abdoli, R. Holland Cheng, Majid Shahbazi. Design and immunogenicity of a recombinant Saccharomyces boulardii secreting the P2-VP8 subunit rotavirus vaccine. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-37374-5
|
| 358 |
Diego Currò, Gianluca Ianiro, Silvia Pecere, Stefano Bibbò, Giovanni Cammarota. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. British Journal of Pharmacology 2017; 174(11) doi: 10.1111/bph.13632
|
| 359 |
Lian-Hua Liu, Bin Han, Jing Tao, Kai Zhang, Xi-Ke Wang, Wen-Yu Wang. The effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication in children: a systematic review and meta-analysis of Randomized controlled trials. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08896-4
|
| 360 |
Yuganthra Balaji, Sai Nandhini Ravi. Exploring microbial probiotics for functional foods enhancing health benefits and industrial processing trends. Food and Humanity 2026; 6 doi: 10.1016/j.foohum.2025.100960
|
| 361 |
Lynne V. McFarland, Charlesnika T. Evans, Ellie J. C. Goldstein. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Frontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00124
|
| 362 |
Bradley C. Johnston, Stephanie S.Y. Ma, Joshua Z. Goldenberg, Kristian Thorlund, Per O. Vandvik, Mark Loeb, Gordon H. Guyatt. Probiotics for the Prevention of Clostridium difficile–Associated Diarrhea. Annals of Internal Medicine 2012; 157(12) doi: 10.7326/0003-4819-157-12-201212180-00563
|
| 363 |
David L. McCollum, J. Martin Rodriguez. Detection, Treatment, and Prevention of Clostridium difficile Infection. Clinical Gastroenterology and Hepatology 2012; 10(6) doi: 10.1016/j.cgh.2012.03.008
|
| 364 |
Harry Sokol, Valentin Leducq, Hugues Aschard, Hang-Phuong Pham, Sarah Jegou, Cecilia Landman, David Cohen, Giuseppina Liguori, Anne Bourrier, Isabelle Nion-Larmurier, Jacques Cosnes, Philippe Seksik, Philippe Langella, David Skurnik, Mathias L Richard, Laurent Beaugerie. Fungal microbiota dysbiosis in IBD. Gut 2017; 66(6) doi: 10.1136/gutjnl-2015-310746
|
| 365 |
S. A. Ryabtseva, A. G. Khramtsov, S. N. Sazanova, R. O. Budkevich, N. M. Fedortsov, A. A. Veziryan. The Probiotic Properties of Saccharomycetes (Review). Applied Biochemistry and Microbiology 2023; 59(2) doi: 10.1134/S0003683823010088
|
| 366 |
Sanaz Kazemi, Aziz Homayouni-Rad, Hossien Samadi Kafil, Vahideh Sarabi-aghdam, Payam Zeynolabedini, Bahareh pour Agha, Sevda Allah Madadi. Selection of appropriate probiotic yeasts for use in dairy products: a narrative review. Food Production, Processing and Nutrition 2025; 7(1) doi: 10.1186/s43014-024-00293-x
|
| 367 |
S.C. Chandrasekar Rajendran, B. Chamlagain, S. Kariluoto, V. Piironen, P.E.J. Saris. Biofortification of riboflavin and folate in idli batter, based on fermented cereal and pulse, byLactococcus lactisN8 andSaccharomyces boulardiiSAA655. Journal of Applied Microbiology 2017; 122(6) doi: 10.1111/jam.13453
|
| 368 |
Andrea Maria Patelski, Ksawery Pragłowski, Katarzyna Pielech-Przybylska, Maria Balcerek, Urszula Dziekońska-Kubczak. Evaluation of Probiotic Saccharomyces boulardii Yeast as a Distillery Strain. Applied Sciences 2025; 15(3) doi: 10.3390/app15031392
|
| 369 |
F.C.P. Tiago, B.A.A. Porto, N.S. Ribeiro, L.M.C. Moreira, R.M.E. Arantes, A.T. Vieira, M.M. Teixeira, S.V. Generoso, V.N. Nascimento, F.S. Martins, J.R. Nicoli. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease. Beneficial Microbes 2015; 6(6) doi: 10.3920/BM2015.0018
|
| 370 |
Francisco Guarner, Mary Ellen Sanders, Hania Szajewska, Henry Cohen, Rami Eliakim, Claudia Herrera-deGuise, Tarkan Karakan, Dan Merenstein, Alejandro Piscoya, Balakrishnan Ramakrishna, Seppo Salminen, Jim Melberg. World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics. Journal of Clinical Gastroenterology 2024; 58(6) doi: 10.1097/MCG.0000000000002002
|
| 371 |
A. Khablenko, S. Danylenko, O. Yalovenko, O. Duhan, O. Potemskaia. POTENTIAL OF USING SACCHAROMYCES BOULARDII TO PRODUCE FERMENTED MILK PRODUCTS. Food Science and Technology 2022; 16(1) doi: 10.15673/fst.v16i1.2290
|
| 372 |
Amir Saber, Beitollah Alipour, Zeinab Faghfoori, Ahmad Yari Khosroushahi. Cellular and molecular effects of yeast probiotics on cancer. Critical Reviews in Microbiology 2017; 43(1) doi: 10.1080/1040841X.2016.1179622
|
| 373 |
Mélanie G. Gareau, Philip M. Sherman, W. Allan Walker. Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews Gastroenterology & Hepatology 2010; 7(9) doi: 10.1038/nrgastro.2010.117
|
| 374 |
Jeppe West Carstensen, Mahtab Chehri, Kristian Schønning, Steen Christian Rasmussen, Jacob Anhøj, Nina Skavlan Godtfredsen, Christian Østergaard Andersen, Andreas Munk Petersen. Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study. European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(8) doi: 10.1007/s10096-018-3267-x
|
| 375 |
Alexander Rapoport. Biotechnology of Yeasts and Filamentous Fungi. Grand Challenges in Biology and Biotechnology 2025; doi: 10.1007/978-3-031-74726-7_12
|
| 376 |
Geoffrey A. Preidis, Colin Hill, Richard L. Guerrant, B.S. Ramakrishna, Gerald W. Tannock, James Versalovic. Probiotics, Enteric and Diarrheal Diseases, and Global Health. Gastroenterology 2011; 140(1) doi: 10.1053/j.gastro.2010.11.010
|
| 377 |
Christoph G Dietrich, Tanja Kottmann, Manuela Alavi. Commercially available probiotic drinks containing <italic>Lactobacillus casei</italic> DN-114001 reduce antibiotic-associated diarrhea. World Journal of Gastroenterology 2014; 20(42): 15837-15844 doi: 10.3748/wjg.v20.i42.15837
|
| 378 |
Simona D'Angelo, Federico Fracassi, Francesca Bresciani, Roberta Galuppi, Alessia Diana, Nikolina Linta, Giuliano Bettini, Maria Morini, Marco Pietra. Effect of Saccharomyces boulardii in dogs with chronic enteropathies: double‐blinded, placebo‐controlled study. Veterinary Record 2018; 182(9) doi: 10.1136/vr.104241
|
| 379 |
Rika Indri Astuti, Muhammad Eka Prastya, Rahayu Wulan, Khairul Anam, Anja Meryandini. Current trends and future perspective of probiotic yeasts research in Indonesia. FEMS Yeast Research 2023; 23 doi: 10.1093/femsyr/foad013
|
| 380 |
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. 2022; doi: 10.2174/9789815051780122010009
|
| 381 |
Qingfang Zeng, Pingdong Li, Huaiyang Wu, Yunying Zhuang, Yonggang Zhang, Sanaz Asemani, Parmida Jamilian, Mehrdad Jamali, Haixia Yu. Probiotics and gastrointestinal disorders: an umbrella meta-analysis of therapeutic efficacy. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02788-w
|
| 382 |
Tithi Kulkarni, Swati Majarikar, Mangesh Deshmukh, Anitha Ananthan, Haribalakrishna Balasubramanian, Anthony Keil, Sanjay Patole. Probiotic sepsis in preterm neonates—a systematic review. European Journal of Pediatrics 2022; 181(6) doi: 10.1007/s00431-022-04452-5
|
| 383 |
Michelle H. Loy. From plate to planet: culturally responsive culinary practices for health system innovation. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1476503
|
| 384 |
Pardeep Kaur, Kusum Dua. Advances in Dairy Microbial Products. 2022; doi: 10.1016/B978-0-323-85793-2.00013-8
|
| 385 |
Marcella Lobato D. Consoli, Raphael Steinberg da Silva, Jacques Robert Nicoli, Oscar Bruña‐Romero, Rodrigo Gomes da Silva, Simone de Vasconcelos Generoso, Maria Isabel T. D. Correia. Randomized Clinical Trial. Journal of Parenteral and Enteral Nutrition 2016; 40(8) doi: 10.1177/0148607115584387
|
| 386 |
Kelly A. Mulholland, Monique G. Robinson, Sharon J. Keeler, Timothy J. Johnson, Bonnie W. Weber, Calvin L. Keeler. Metagenomic Analysis of the Respiratory Microbiome of a Broiler Flock from Hatching to Processing. Microorganisms 2021; 9(4) doi: 10.3390/microorganisms9040721
|
| 387 |
Iyad Issa, Rami Moucari. Probiotics for antibiotic-associated diarrhea: Do we have a verdict?. World Journal of Gastroenterology 2014; 20(47): 17788-17795 doi: 10.3748/wjg.v20.i47.17788
|
| 388 |
Joshua Z Goldenberg, Lyubov Lytvyn, Justin Steurich, Patricia Parkin, Sanjay Mahant, Bradley C Johnston. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews 2015; doi: 10.1002/14651858.CD004827.pub4
|
| 389 |
John R. Ferguson, Karen Taylor. Probiotics for Antibiotic-Associated Diarrhea: What, When, and How Long?. International Journal of Clinical Medicine 2022; 13(12) doi: 10.4236/ijcm.2022.1312043
|
| 390 |
Przemysław Gałązka, Aleksandra Baska, Jakub Kazik, Kamil Leis.
Saccharomyces Cerevisiae Var. Boulardii In Irritable Bowel Syndrome. Postępy Mikrobiologii - Advancements of Microbiology 2020; 59(1) doi: 10.21307/PM-2020.59.1.004
|
| 391 |
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova, E. A. Belousova, P. A. Makarchuk, E. Yu. Eremina, A. S. Sarsenbaeva, D. I. Abdulganieva, L. V. Tarasova, O. A. Gromova, V. A. Ratnikov, K. V. Kozlov, A. K. Ratnikova. Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). Experimental and Clinical Gastroenterology 2021; (3) doi: 10.31146/1682-8658-ecg-187-3-5-82
|
| 392 |
Mary O'Connell Motherway, Lisa O'Connor, Shaun Smith, Declan Bolton, Martin Cormican, Theo De Waal, Montserrat Gutierrez, Ms Ann Marie Part, Fiona Walsh, Geraldine Duffy. Assessment of the safety of “probiotics” in food supplements. Food Risk Assess Europe 2024; 2(4) doi: 10.2903/fr.efsa.2024.FR-0050
|
| 393 |
Wardah Alsalemi, Zamri Chik, Mohammed Abdullah Alshawsh, Awatif Abid Al-Judaibi. Probiotic bacteria vs. yeast for gastrointestinal diseases treatment: Protocol for a systematic review and meta-analysis. PLOS One 2025; 20(6) doi: 10.1371/journal.pone.0324926
|
| 394 |
C. Villot, Y. Chen, K. Pedgerachny, F. Chaucheyras-Durand, E. Chevaux, A. Skidmore, L.L. Guan, M.A. Steele. Early supplementation of Saccharomyces cerevisiae boulardii CNCM I-1079 in newborn dairy calves increases IgA production in the intestine at 1 week of age. Journal of Dairy Science 2020; 103(9) doi: 10.3168/jds.2020-18274
|
| 395 |
Josemar Gonçalves de Oliveira Filho, Mariana Buranelo Egea, Wanli Zhang, Ananthi Pandi, Katia Sivieri, Mateus Kawata Salgaço, Leonardo Sentanin, Anna Rafaela Cavalcante Braga, Michael Jones da Silva, Luiz Henrique Cappareli Mattoso. Polymeric nanofibers as advanced probiotic carriers: Production strategies, functional performance, and emerging applications. Food Bioscience 2025; 73 doi: 10.1016/j.fbio.2025.107684
|
| 396 |
Alexandru Cosmin Pantazi, Cristina Maria Mihai, Adriana Luminita Balasa, Tatiana Chisnoiu, Ancuta Lupu, Corina Elena Frecus, Larisia Mihai, Adina Ungureanu, Mustafa Ali Kassim Kassim, Antonio Andrusca, Maria Nicolae, Viviana Cuzic, Vasile Valeriu Lupu, Simona Claudia Cambrea. Relationship between Gut Microbiota and Allergies in Children: A Literature Review. Nutrients 2023; 15(11) doi: 10.3390/nu15112529
|
| 397 |
H. Szajewska, A. Horvath, M. Kołodziej. Systematic review with meta‐analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2015; 41(12) doi: 10.1111/apt.13214
|
| 398 |
Min-Kyoung Shin, Han Sang Yoo. Animal vaccines based on orally presented yeast recombinants. Vaccine 2013; 31(40) doi: 10.1016/j.vaccine.2013.07.029
|
| 399 |
Nienke van Staaveren, Julia Krumma, Paul Forsythe, Joergen B. Kjaer, Isabelle Y. Kwon, Yu-Kang Mao, Christine West, Wolfgang Kunze, Alexandra Harlander-Matauschek. Cecal motility and the impact of Lactobacillus in feather pecking laying hens. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-69928-6
|
| 400 |
Lesha Pretorius, Anton du Preez Van Staden, Johannes J. Van der Merwe, Natasha Henning, Carine Smith. Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome. Inflammopharmacology 2022; 30(1) doi: 10.1007/s10787-021-00906-8
|
| 401 |
Karolina Sala, Maëlys Bradier, Elise Bonjour, Azza Silotry Naik. Microalgae-Based Probiotic Delivery Systems: Nutritional, Functional, and Synbiotic Potential – A Review. Current Food Science and Technology Reports 2026; 4(1) doi: 10.1007/s43555-026-00084-0
|
| 402 |
Tieraona Low Dog. Smart Talk on Supplements and Botanicals: Pre- and Post-Operative Surgical Care. Alternative and Complementary Therapies 2010; 16(3) doi: 10.1089/act.2010.16312
|
| 403 |
Dawood Aghamohammadi, Hormoz Ayromlou, Neda Dolatkhah, Fatemeh Jahanjoo, Seyed Kazem Shakouri. The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial. Trials 2019; 20(1) doi: 10.1186/s13063-019-3454-9
|
| 404 |
Wei Dai, Xiaofan Chen, Huanhuan Zhou, Ning Liu, Mengdi Jin, Zhi Guo. Microbiota modulation for infectious complications following allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1509612
|
| 405 |
Nina Okuka, Neda Milinkovic, Ksenija Velickovic, Snezana Polovina, Mirjana Sumarac-Dumanovic, Rajna Minic, Davor Korčok, Brizita Djordjevic, Nevena Dj. Ivanovic. Beneficial effects of a new probiotic formulation on adipocytokines, appetite-regulating hormones, and metabolic parameters in obese women. Food & Function 2024; 15(14) doi: 10.1039/D4FO01269K
|
| 406 |
Dana D. Byrne, Annette C. Reboli. Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special Considerations. Current Clinical Microbiology Reports 2017; 4(4) doi: 10.1007/s40588-017-0073-7
|
| 407 |
Maria Theodorakopoulou, Elias Perros, Evangelos J. Giamarellos-Bourboulis, George Dimopoulos. Controversies in the management of the critically ill: the role of probiotics. International Journal of Antimicrobial Agents 2013; 42 doi: 10.1016/j.ijantimicag.2013.04.010
|
| 408 |
Maciej Piotr Szota, Katarzyna Napiórkowska-Baran, Aleksandra Wojtkiewicz, Lidia Wydeheft, Adam Wawrzeńczyk, Józef Sławatycki, Paweł Treichel, Ewa Alska, Barbara Zyśk, Krzysztof Pałgan. Current Understanding of Probiotic Strains and Immune Function: From Gut Microbiota to Systemic Immunity. International Journal of Molecular Sciences 2026; 27(10) doi: 10.3390/ijms27104527
|
| 409 |
Rodolphe Pontier-Bres, Patrick Munro, Laurent Boyer, Rodolphe Anty, Véronique Imbert, Chloé Terciolo, Fréderic André, Patrick Rampal, Emmanuel Lemichez, Jean-François Peyron, Dorota Czerucka, Stefan Bereswill. Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal Tract. PLoS ONE 2014; 9(8) doi: 10.1371/journal.pone.0103069
|
| 410 |
Vandana Bharat Patravale, Amita Keertimaan Joshi. Nutraceutical and Functional Foods in Disease Prevention. Advances in Human Services and Public Health 2019; doi: 10.4018/978-1-5225-3267-5.ch001
|
| 411 |
Sejuti Ray Chowdhury, Arup Dey, Manish Kumar Gautam, Sandip Mondal, Sharad D. Pawar, Anagha Ranade, Manajit Bora, Mayank Gangwar, Aniya Teli, Nur Shaid Mondal. Immune-mediated Bowel Disease: Role of Intestinal Parasites and Gut Microbiome. Current Pharmaceutical Design 2024; 30(40) doi: 10.2174/0113816128326270240816075025
|
| 412 |
Angelika Pirker, Alexander Stockenhuber, Marlene Remely, Anna Harrant, Berit Hippe, Christoph Kamhuber, Krista Adelmann, Felix Stockenhuber, Alexander G. Haslberger. Effects of antibiotic therapy on the gastrointestinal microbiota and the influence ofLactobacillus casei. Food and Agricultural Immunology 2013; 24(3) doi: 10.1080/09540105.2012.689816
|
| 413 |
Janice Walton, Denise Burns, Kay E. Gaehle. Process and Outcome of Fecal Microbiota Transplants in Patients With Recurrent Clostridium difficile Infection. Gastroenterology Nursing 2017; 40(5) doi: 10.1097/SGA.0000000000000233
|
| 414 |
Francesco Di Pierro, Aswin Thacharodi, Muthiah Kumaraswami, Alexander Suvorov, Jure Zupet, Nicola Zerbinati. From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics. Microbial Cell Factories 2026; 25(1) doi: 10.1186/s12934-026-02997-w
|
| 415 |
Claudia Cappella, Chiara Redaelli, Melissa Balzarotti, Pasquale Scarcia, Gennaro Agrimi, Maurizio Bettiga.
Rethinking probiotics: breaking the
Lactobacillus
-
Bifidobacterium
duopoly in the management of dysbiosis and allergies
. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2673679
|
| 416 |
Anastasia Nijnik. Immunomodulatory approaches for prevention and treatment of infectious diseases. Current Opinion in Microbiology 2013; 16(5) doi: 10.1016/j.mib.2013.06.011
|
| 417 |
Ida M. Smith, Adam Baker, Jeffrey E. Christensen, Teun Boekhout, Hanne Frøkiær, Nils Arneborg, Lene Jespersen, Ilse D. Jacobsen. Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro. PLOS ONE 2016; 11(11) doi: 10.1371/journal.pone.0167410
|
| 418 |
S. Shamekhi, H. Lotfi, J. Abdolalizadeh, E. Bonabi, N. Zarghami. An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer. Clinical and Translational Oncology 2020; 22(8) doi: 10.1007/s12094-019-02270-0
|
| 419 |
Tong Li, Lynne Vernice McFarland. Saccharomyces boulardii CNCM I-745 and smectite treatment for pediatric acute gastroenteritis in China: a systematic review and meta-analysis. Frontiers in Pediatrics 2026; 14 doi: 10.3389/fped.2026.1747695
|
| 420 |
Sultan Arslan, Mustafa Erbas, Ismail Tontul, Ayhan Topuz. Microencapsulation of probiotic Saccharomyces cerevisiae var. boulardii with different wall materials by spray drying. LWT - Food Science and Technology 2015; 63(1) doi: 10.1016/j.lwt.2015.03.034
|
| 421 |
Rebecka Ventin-Holmberg, Anja Eberl, Schahzad Saqib, Katri Korpela, Seppo Virtanen, Taina Sipponen, Anne Salonen, Päivi Saavalainen, Eija Nissilä. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021; 15(6) doi: 10.1093/ecco-jcc/jjaa252
|
| 422 |
|
| 423 |
H. Szajewska, M. Kołodziej. Systematic review with meta-analysis:Lactobacillus rhamnosusGG in the prevention of antibiotic-associated diarrhoea in children and adults. Alimentary Pharmacology & Therapeutics 2015; 42(10) doi: 10.1111/apt.13404
|
| 424 |
Charlotte Cordonnier, Jonathan Thévenot, Lucie Etienne-Mesmin, Sylvain Denis, Monique Alric, Valérie Livrelli, Stéphanie Blanquet-Diot. Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota. Microorganisms 2015; 3(4) doi: 10.3390/microorganisms3040725
|
| 425 |
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council 2020; (5) doi: 10.21518/2079-701X-2020-5-104-112
|
| 426 |
Bhavna Darshan Patel, Girish Kulkarni, Swagata Chowdhuri, Animesh Arya, Kaithayil Mammen John, Ashwini Suyog Patki Doshi, Rathish Nair, Krishnaprasad Korukonda. Evaluation of Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus, Lactobacillus sporogenes, Saccharomyces Boulardi multistrain probiotic formulation in acute gastroenteritis: a real-world observational study (MAESTRO). BMC Nutrition 2025; 11(1) doi: 10.1186/s40795-025-01127-w
|
| 427 |
A.S.R. Hudson, A.M.T. Lisboa, P.V.R. Andrade, R.S. Bruzzi, Y.A.T. Martins, D.D. Soares, F.S. Martins, S.P. Wanner. Saccharomyces boulardii supplementation does not affect anaerobic power gain induced by short-term sprint interval training in physically active individuals. Brazilian Journal of Medical and Biological Research 2025; 58 doi: 10.1590/1414-431x2025e14196
|
| 428 |
Sanjeeva Kumar Murali, Thomas J. Mansell. Next generation probiotics: Engineering live biotherapeutics. Biotechnology Advances 2024; 72 doi: 10.1016/j.biotechadv.2024.108336
|
| 429 |
Zaigham Abbas, Javed Yakoob, Wasim Jafri, Zubair Ahmad, Zahid Azam, Muhammad W. Usman, Sara Shamim, Muhammad Islam. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2014; 26(6) doi: 10.1097/MEG.0000000000000094
|
| 430 |
Qi Yin, Samriddhi Gupta, Efrat Muller, Alexandre Almeida. The human gut microbiome in enteric infections: from association to translation. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2612836
|
| 431 |
Dan He, Hai-Yang Wang, Jing-Yan Feng, Ming-Ming Zhang, Yong Zhou, Xiao-Ting Wu. Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: A meta-analysis of randomized controlled trials. Clinics and Research in Hepatology and Gastroenterology 2013; 37(4) doi: 10.1016/j.clinre.2012.10.007
|
| 432 |
O. Ellouze, V. Berthoud, M. Mervant, J.P. Parthiot, C. Girard. Septic shock due to Saccharomyces boulardii. Médecine et Maladies Infectieuses 2016; 46(2) doi: 10.1016/j.medmal.2015.12.003
|
| 433 |
Eamonn MM Quigley. Gut microbiota and the role of probiotics in therapy. Current Opinion in Pharmacology 2011; 11(6) doi: 10.1016/j.coph.2011.09.010
|
| 434 |
Adam Staniszewski, Monika Kordowska-Wiater. Probiotic and Potentially Probiotic Yeasts—Characteristics and Food Application. Foods 2021; 10(6) doi: 10.3390/foods10061306
|
| 435 |
Beyza Sayman, Remziye Yılmaz.
Differentiation of
Saccharomyces boulardii
from
Saccharomyces cerevisiae
Strains Using the qPCR-HRM Technique Targeting
AAD15
Gene
. Food Biotechnology 2024; 38(3) doi: 10.1080/08905436.2024.2382862
|
| 436 |
Themistoklis Katsimichas, Alexios S Antonopoulos, Alexandros Katsimichas, Tomohito Ohtani, Yasushi Sakata, Dimitris Tousoulis. The intestinal microbiota and cardiovascular disease. Cardiovascular Research 2019; 115(10) doi: 10.1093/cvr/cvz135
|
| 437 |
Thao M. Ho, Amin Yousefvand, Heikki Suhonen, Per E.J. Saris, Kirsi S. Mikkonen. Protective role of wood hemicelluloses: Enhancing yeast probiotics survival in spray drying and storage. Future Foods 2024; 10 doi: 10.1016/j.fufo.2024.100437
|
| 438 |
Deniz Güney Duman, Zarife Nigâr Özdemir Kumral, Feriha Ercan, Mustafa Deniz, Güray Can, Berrak Çağlayan Yeğen. Saccharomyces boulardiiameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats. British Journal of Nutrition 2013; 110(3) doi: 10.1017/S000711451200517X
|
| 439 |
Mariana L. Palma, Daniel Zamith-Miranda, Flaviano S. Martins, Fernando A. Bozza, Leonardo Nimrichter, Mônica Montero-Lomeli, Ernesto T. A. Marques, Bruno Douradinha. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?. Applied Microbiology and Biotechnology 2015; 99(16) doi: 10.1007/s00253-015-6776-x
|
| 440 |
Katarzyna Roeske, Aleksandra Zasuń, Justyna Cieślik, Marta Wróblewska, Tomasz Jagielski.
Saccharomyces Cerevisiae Var. Boulardii Probiotic Yeasts As Etiological Agents Of Oportunistic Infections In Humans. Postępy Mikrobiologii - Advancements of Microbiology 2020; 59(3) doi: 10.21307/PM-2020.59.3.21
|
| 441 |
S J M Ten Bruggencate, S A Girard, E G M Floris-Vollenbroek, R Bhardwaj, T A Tompkins. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study. European Journal of Clinical Nutrition 2015; 69(3) doi: 10.1038/ejcn.2014.238
|
| 442 |
Abhijit Banik, Suman Kumar Halder, Chandradipa Ghosh, Keshab Chandra Mondal. Recent Advancement in White Biotechnology Through Fungi. Fungal Biology 2019; doi: 10.1007/978-3-030-14846-1_3
|
| 443 |
Theodoros Kelesidis, Charalabos Pothoulakis. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology 2012; 5(2) doi: 10.1177/1756283X11428502
|
| 444 |
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, Francesco Marotta. Probiotics as Live Biotherapeutics for Veterinary and Human Health, Volume 2. 2024; doi: 10.1007/978-3-031-65459-6_33
|